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Abstract
Improvements in military trauma care during the wars in Afghanistan and Iraq have contributed to
increased survival rates for combat-injured American military personnel. Yet, little is understood about the
short- and long-term physical and mental health symptoms resulting from these injuries. Understanding
clinical presentations and symptom trajectories in survivors of complex combat injuries is paramount to
the future development and implementation of interventions that are capable of reducing the disabling
effects of symptoms and, subsequently, improving health outcomes across the continuum of trauma
care. This dissertation addresses the key question: in an era of unprecedented survival after complex and
life-threatening injuries, what are the short- and long-term symptom trajectories of post-traumatic stress
disorder (PTSD) and pain, even after exposure to pain management interventions, specifically regional
anesthesia (RA)? Furthermore, this investigation evaluates the effectiveness of RA on reducing pain
intensity after injury. To address these inquiries, this dissertation used the longitudinal data from one of
the largest and most comprehensive datasets of patient-reported outcomes from American military
personnel and veterans wounded in action during Operation Enduring Freedom and Operation Iraqi
Freedom. Principle findings were: 1) There is an established association between pain and mental health
symptom presentations in combat-injured military personnel and veteran populations that exists
throughout care settings where nurses are practicing; 2) PTSD symptom severity, and pain intensity and
interference are significantly correlated up to twenty-one months after injury; 3) Worsening PTSD
symptom trajectories are associated with higher pain intensity after injury compared to improving or
stable PTSD symptom trajectories; 4) Early receipt of RA for pain management following combat injury is
associated with improved patient-reported pain outcomes; 5) Markov chains are a practical method for
characterizing probabilistic pain trajectories after combat injury, and can be beneficial in future work to
examine the benefits of analgesic interventions. Results inform future directions for advancing nursing
science research and directing practice, in the context of implementing interventions to manage pain
after serious injury in order to maximize recovery across military, veteran, and civilian populations.
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ABSTRACT
FROM THE FRONTLINE TO THE COMMUNITY:
THE USE OF REGIONAL ANESTHESIA AFTER COMBAT INJURY AND
ASSOCIATED PAIN OUTCOMES
Nicholas A. Giordano
Rosemary C. Polomano, PhD, RN, FAAN
Improvements in military trauma care during the wars in Afghanistan and Iraq have
contributed to increased survival rates for combat-injured American military personnel.
Yet, little is understood about the short- and long-term physical and mental health
symptoms resulting from these injuries. Understanding clinical presentations and
symptom trajectories in survivors of complex combat injuries is paramount to the future
development and implementation of interventions that are capable of reducing the
disabling effects of symptoms and, subsequently, improving health outcomes across the
continuum of trauma care. This dissertation addresses the key question: in an era of
unprecedented survival after complex and life-threatening injuries, what are the shortand long-term symptom trajectories of post-traumatic stress disorder (PTSD) and pain,
even after exposure to pain management interventions, specifically regional anesthesia
(RA)? Furthermore, this investigation evaluates the effectiveness of RA on reducing pain
intensity after injury. To address these inquiries, this dissertation used the longitudinal
data from one of the largest and most comprehensive datasets of patient-reported
outcomes from American military personnel and veterans wounded in action during
Operation Enduring Freedom and Operation Iraqi Freedom. Principle findings were: 1)
vii

There is an established association between pain and mental health symptom
presentations in combat-injured military personnel and veteran populations that exists
throughout care settings where nurses are practicing; 2) PTSD symptom severity, and
pain intensity and interference are significantly correlated up to twenty-one months after
injury; 3) Worsening PTSD symptom trajectories are associated with higher pain
intensity after injury compared to improving or stable PTSD symptom trajectories; 4)
Early receipt of RA for pain management following combat injury is associated with
improved patient-reported pain outcomes; 5) Markov chains are a practical method for
characterizing probabilistic pain trajectories after combat injury, and can be beneficial in
future work to examine the benefits of analgesic interventions. Results inform future
directions for advancing nursing science research and directing practice, in the context of
implementing interventions to manage pain after serious injury in order to maximize
recovery across military, veteran, and civilian populations.
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CHAPTER 1
Introduction
Since the terrorist attacks on September 11, 2001 in the United States (U.S.), over 2.5
million American service members deployed to engage in counterterrorism efforts
globally.1 Service members operating on the front-lines of combat zones encounter
modern warfare weaponry, including high intensity weapons and improvised explosive
devices (IED) that have the potential to inflict unprecedented injury patterns and
severity.2,3 During the past 17 years of these global conflicts, more than 50,000 service
members have been wounded in action.4 Many of these service members have sustained a
multitude of injuries across several organ systems and anatomical regions of the body,
known as polytrauma.5 For the first time in U.S. warfare history, the majority of these
combat wounds are survivable despite their magnitude and severity, largely due to
advancements in military trauma care.6 This survivability means individuals are living
with serious injuries that were previously considered fatal. Therefore, changes are needed
in the management of both acute and chronic injury-related pain. Moreover, little is
understood about the long-term physical and mental health symptom trajectories among
survivors of polytrauma.
Progress in combat casualty care extends to military hospital care and comprehensive
rehabilitative service where the toll of warfare is evident in both the visible and invisible
wounds of war. Chronic pain and post-traumatic stress disorder (PTSD) are frequently
observed together among veterans returning from Operation Enduring Freedom (OEF)
and Operation Iraqi Freedom (OIF).7,8 Estimates show 30% to 68% of injured OEF/OIF
1

veterans experience symptoms of PTSD, and over 80% report experiencing chronic
pain.9-11 Chronic pain is associated with PTSD, functional impairment, behavioral health
issues, and compromised health-related quality of life.12-14 Combat-injured military
personnel report worse pain and more severe mental and physical health symptoms than
noncombat injured personnel exposed to similar wartime stressors.15-18 Veterans with
comorbid symptoms have increased care utilization and almost double the costs of care
within the Veterans Health Administration (VHA), a division of the U.S. Department of
Veterans Affairs (VA), than those with chronic pain or PTSD alone.19
Early pain interventions in the combat theater, during transportation, and throughout
acute care hospitalization improve pain outcomes20-24 and potentially reduce the risk of
developing mental health illnesses after combat injury.25,26 Traumatic tissue damage
inflicted by combat injuries, triggers an extensive inflammatory reaction consisting of the
release of neurotransmitters to elicit an intracellular and neuropsychological response.27
When undermanaged, this persistent inflammatory response can lead to chronic pain. The
initial management of acute pain may benefit injured persons by interrupting this cascade
of neurotransmitters.28 This interruption may mitigate the development of chronic pain
and thereby limit the interactions between pain intensity and PTSD symptom severity that
can contribute to disability.29 Comprehensive pain management, delivered as close as
possible to the time of injury, is essential for all seriously injured persons. Despite robust
research in the field of analgesics used after combat injury for improving pain
management, the mechanisms of optimal delivery of anesthesia and analgesia after
serious injury remains under researched.30,31 Since most who sustain serious injuries will
2

survive, it is critical to ensure that injured service members have every opportunity to
return home with minimal pain.
Purpose and Outline of the Research
This chapter is a brief overview of the dissertation and contextualizes this research. The
purpose of this work is to identify the complex interrelatedness of pain and mental health
conditions, such as PTSD, and the reciprocal influence symptoms have after combat
injury. Additionally, this work evaluates the effects of early pain management after
combat related-injury on pain intensity and interference. The chapter provides a brief
summary and rationale of terms used throughout the dissertation. The intervention of
interest, regional anesthesia (RA), is introduced and its utility in addressing the pain
management challenges of combat-injured persons is discussed. An overview of the aims
of each chapter follows before considering the significance of this work.
Subsequent chapters include the three component papers that comprise this
dissertation. Initially, an integrative review of the extant literature was undertaken in
order to identify clinical presentations and relationships between PTSD, depression, and
pain after injury among OEF/OIF military personnel and veterans (Chapter 2). The
remaining chapters detail a secondary analysis of the longitudinal data from the Regional
Anesthesia Military Battlefield Pain Outcomes Study (RAMBPOS) (Chapters 3 and 4).
Finally, the dissertation concludes with a discussion on leveraging the findings of this
symptom science research to inform future pain management approaches in order to
improve short- and long-term health outcomes after serious injury (Chapter 5).
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RAMBPOS is a prospective longitudinal cohort study investigating the effects of
early aggressive RA following major combat-related limb injuries on subsequent pain,
functional status, behavioral health, and health related quality of life outcomes.32
Individuals received RA either in a combat support hospital, during evacuation
transportation, upon arrival to a U.S. military medical facility, intraoperatively, or
throughout acute care. Individuals not receiving RA within two months of injury received
conventional systemic pain management. Military personnel hospitalized with at least
one major limb combat-related injury between 2007 and 2014 were eligible for
enrollment during acute care or inpatient physical rehabilitation at one of two domestic
U.S. military treatment facilities. Participants were excluded if they sustained major head
trauma with cognitive deficits, defined as moderate or severe traumatic brain injury
(TBI), had an inability to concentrate, clinician observed poor judgment and impulse
control, substantial hearing loss, and individuals with bilateral upper extremity
amputation with no alternate means to complete survey forms. Exclusion criteria were
implemented due to potential cognitive inability to provide patient-reported outcomes.
The final sample of 386 combat-injured participants provided sociodemographic,
pain, behavioral health, and injury data. After being screened and enrolled during acute
care or rehabilitation, participants could join RAMBPOS anytime within two years after
injury. Over the telephone, patient-reported outcomes were collected monthly in the first
six months after injury and every three months thereafter, up to two years post-injury
(See study schema in Figure 1-1). Retrospective abstraction of injury and clinical care
data from health records during the initial hospitalization at military facilities were
4

integrated into the dataset, including pertinent injury information, receipt of early RA,
and other multimodal pain therapies. The study was an interdisciplinary partnership
between providers and researchers at Walter Reed National Military Medical Center,
Brooke Army Medical Center, Veterans Affairs Office of Research and Development,
Defense & Veterans Center for Integrative Pain Management, and the University of
Pennsylvania.
Definition of Terms
Polytrauma
Due to the proliferation of high velocity weapons and IEDs employed in modern warfare,
it is important to examine the complex injury patterns and mechanisms sustained by U.S.
military personnel in Iraq and Afghanistan. Polytrauma is defined as injuries to multiple
organ systems and anatomical regions of the body, most often due to blast exposure.
Polytrauma comprises internal bleeding, major extremity injuries, TBIs, and other
neurological injuries.5 Nearly three quarters of all combat casualties in OEF/OIF are the
result of explosive mechanisms.3 These intense explosive reactions catalyze a pressurized
blast wave that cause compression and shearing of tissue, damage to gas-filled organs
(e.g. lungs), and TBI. Subsequent injuries after a blast, include blunt or penetrating
injuries as materials from within a bomb casing and environmental debris are carried with
the explosion.33 All participants in RAMBPOS experienced at least one major limb injury
and sustained a mild TBI (mTBI) given the mechanisms of their injuries. For the purpose
of this dissertation, polytrauma is inclusive of major limb injuries, and severe or serious
injuries.
5

Pain
Pain is an expected response to severe injury. Pain is defined as “the unpleasant sensory
and emotional experience associated with actual or potential tissue damage, or described
in terms of such damage”.35 The tissue damage induced by severe physical trauma
initiates an inflammatory response of neurotransmitters that heightens both peripheral and
central nervous system sensitization. Prolonged activation of this inflammatory response
and nociception can cause a reduction in pain thresholds, allodynia, and an increased
reaction to noxious stimuli, hyperalgesia.36 These processes ultimately lead to
maladaptive neuroplasticity, the remodeling of neuronal structures that can contribute to
the transition from acute pain response to chronic pain.27 Chronic pain is pain that
persists beyond the expected time of healing; three months is the most often used point of
division between acute and chronic pain.35 About 60% of severely injured civilians
experience injury-related pain a year after trauma care.37 In comparison, over 80% of
combat-injured veterans report experiencing chronic pain between 6 to 8 months after
injury.10,12
Pain is a multidimensional phenomenon, requiring several levels of measurement in
order to accurately capture an individual’s painful experience.29,38 Subjective pain
intensity is a common measure in clinical practice and research. Pain intensity is defined
as the severity to which pain is experienced. Common assessments of pain intensity
include numeric rating scales where zero (0) refers to no pain, and ten (10) is the greatest
severity, or most intense, pain can be experienced. However, pain is an inherently
subjective experience and individuals interpret measurement scales differently. As such,
6

it is imperative pain intensity be evaluated beyond just what a research participant or
patient is currently experiencing at time of assessment.39 Measuring different components
of pain, such as worst pain or least pain experienced in the past 24 hours, can provide
valuable insight between assessment points in prospective research. Measuring the
multiple dimensions of pain, such as worst, least, and current pain, is important to
capturing patient’s total pain experience. Pain interference is defined as the impact of
pain on daily living and functioning.40,41 The extent of pain interference refers to how
pain hinders a person’s engagement with social, cognitive, emotional, physical, and
recreational activities. When measured and discussed together, in this research, pain
intensity and interference are referred to as patient-reported pain outcomes, or simply
pain outcomes.
Post-traumatic Stress Disorder (PTSD)
PTSD is a mental health condition that can develop after experiencing a traumatic and/or
dangerous event, such as combat injury. Physical trauma can cause a dysregulation of
multiple biological stress-mediating systems.42 While individuals’ responses to trauma
differ, it is common to experience symptoms of post-traumatic stress (PTS). To be
diagnosed with PTSD, an individual needs to present with one re-experiencing symptom
(e.g. nightmares, flashbacks), three avoidance symptoms (e.g. loss of interest, amnesia,
social detachment), and two hyperarousal or reactivity-related symptoms (e.g. difficulty
sleeping, hypervigilance) out of 17 qualifying PTS symptoms for at least one month that
impairs an area of their functioning, according to the American Psychiatric Association’s
4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV).43
7

Not all combat-injured individuals will develop PTSD. On average, 11% to 20% of
OIF/OEF veterans have a PTSD diagnosis in a given year;44 with a higher proportion,
between 30% to 68%, observed in combat-injured veterans.9,12,14 For the purpose of this
dissertation the term PTSD (DSM-IV criteria) will be used throughout when referring to
both PTSD and PTS. The Diagnostic and Statistical Manual for Mental Disorders, Fifth
Edition (DSM-5) was published after RAMBPOS screening and enrollment was
completed. Therefore, the DSM-IV criteria for PTSD were utilized to ensure continuity
throughout the study period across participants.
Symptom Trajectories
Symptom trajectories, as defined in this dissertation, are changes in a disease’s or a
condition’s clinical presentation over time. Evaluating symptom trajectories is essential
to identifying interceding points when effective interventions, capable of altering the
course of symptoms, can be used in clinical practice. Moreover, investigations of disease
specific symptom trajectories can enable the identification of pathways that change the
severity of co-occurring symptoms, or symptom clusters, and inform best strategies for
managing conditions simultaneously. Due to the frequent co-presentation of both pain
and PTSD in veterans (50% to 80% of veterans diagnosed with PTSD report
experiencing chronic pain),9,12,46 it is of value to consider the potential influence
symptom trajectories have on one another.
Pain after injury is dynamic and requires longitudinal assessment by clinicians and
researchers. Pain trajectories offer valuable insight into understanding clinical
presentations of pain after combat injury.47 Current evaluations of post-combat injury
8

pain are predominantly cross-sectional21,24,48 and divided between understanding acute
pain or chronic pain presentations.18,22,26 Previous investigations on acute postoperative
pain demonstrate the utility in capturing pain trajectories.47,49 For example, there is mixed
evidence to support that acute pain trajectories, specifically individuals with high pain
intensity, can predict the development of post-surgical chronic pain several months
later.50 There is a value to understanding acute pain trajectories given that they provide
greater information of change in pain intensity over time than conventional intermittent
assessments, while also improving measurement precision.47,49,51 Since pain intensity is
subjective, it is necessary to assess intra-individual fluctuations in response to acute pain
interventions and chronic pain prevention strategies.52 Considering pain trajectories are
dynamic in nature, simple linear modeling may be inadequate to other statistical
approaches, such as mixed effects modeling47 or probabilistic Markov modeling.53
Markov modeling has been demonstrated to be a feasible method for simulating disease
processes, including postoperative pain trajectories,53 but has yet to be applied in
characterizing post-combat injury pain trajectories. Markov modeling allows for the
creation of pain states, defined as a quantified measure of pain intensity at a discrete time
point in recovery after injury. The transition from one pain state to another (i.e.
fluctuations in pain intensity) over time, can be considered a trajectory.
PTSD symptoms also have a variable course after traumatic events that can be acute
or chronic, with symptoms fluctuating, remitting, or even worsening.44,54 Therefore,
capturing PTSD symptom trajectories after injury are of vital importance in order to
inform care throughout recovery. The majority of studies following trauma exposed
9

persons, often do not exceed one year of evaluation and do not include more than two
assessment points.55 However, a few of the longitudinal investigations that do exist
highlight the diverse presentations of PTSD symptom trajectories, and that subsyndromal
levels of PTSD can contribute to disability and inhibit recovery.56 This sub-threshold
PTSD symptom severity is the most common trajectory seen in OEF/OIF military
personnel and veterans.57 However, more research is required to examine distal health
outcomes predicted by PTSD symptom trajectories.58
Regional Anesthesia (RA)
Early pain management interventions, including RA, are paramount in the immediate
post-traumatic injury period and throughout acute care hospitalization. RA is an effective
and efficient intervention to manage acute pain and improve pain outcomes.24,48,59-61
When used as part of a multimodal regimen, RA can target discrete components of the
peripheral and central pain pathways to provide effective analgesia at lower opioid dosing
and producing fewer adverse effects than standard systemic anesthesia and analgesic
approaches.62 Multimodal analgesia refers to the combination of analgesic drugs from
different classes that have a synergistic effect and can maximize reductions in pain
intensity at lower doses and reduced dependence on opioids.62 RA delivered in
RAMBPOS includes the use of neuraxial anesthesia, the local administration of an
anesthetic into the spinal cord’s epidural or intrathecal space, as well as peripheral nerve
blocks, directed towards an isolated nerve or plexus through the injection of a local
anesthetic under ultrasound guidance. These RA techniques allow for a high precision
delivery of analgesia to injured areas of the body to augment multimodal regimens.
10

The austere environment, combined with the complex care associated with combat
trauma, necessitates the use of agile and effective pain management interventions. For
example, systemic pain therapies come with challenges, including timeliness of
administration and therapeutic effect.62 General anesthesia requires advanced logistics,
such as availability of a dependable source of electricity and compressed gas that are not
always available in the battlefield. Use of RA, is hypothesized to reduce complications in
civilian surgical patients.62-65 Improved outcomes with RA, over systemic approaches,
include the avoidance of intubation and mechanical ventilation, minimal risk of
respiratory and circulatory depression, and improved postoperative analgesia.31,65 After
being introduced in the Vietnam War, RA is now commonly used to manage pain
following injuries in both Iraq and Afghanistan. In military and the civilian populations
RA has proven benefits of optimal acute pain severity control with fewer side effects,
minimal or non-opiate therapy, and improved functional recovery.26,31,59,65-67 A metaanalysis comparing RA to conventional analgesia (e.g. intermittent opioids) found RA to
be effective in preventing persistent postoperative pain, a type of chronic pain, in civilian
populations up to one year after surgery.68 Yet, this analysis did not include studies with
combat-injured OEF/OIF military personnel, and results were weakened due to both
small samples and the limited availability of data beyond one year. A cross-sectional
study of OEF/OIF amputees identified individuals who received pain management
through RA had over 50% lower odds of developing subtypes of chronic pain, than
amputees not receiving RA.69
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Chapter Aims and Rationale
The following chapter aims were designed to achieve the goals this dissertation, which
were to identify the complex interrelatedness of pain and mental health, and the effects of
RA on patient-reported outcomes after combat related-injury.
Chapter 2
Aim: This integrative review synthesized clinical presentations and interrelationships
among characteristics and mechanisms of combat injury, PTSD, depression and pain in
American military service members and veterans serving in OEF/OIF wars. This paper
provides an evidence table of clinical presentations of these often co-occurring conditions
and injury characteristics that helps to contextualize the RAMBPOS participants. The
results of this review are foundational to understanding combat trauma for the data-based
papers that follow.
Rationale: The interrelationships and presentations identified in this review of the
literature establish a clinical knowledge base for this dissertation and future lines of
inquiry in the field of combat injury science. This essential review of the literature is one
of the first to examine the polytrauma phenomenon from the nursing science perspective.
Chapter 3
Aim: Evaluate the association of RA and PTSD symptom trajectories, on pain intensity
and interference over the first two years after injury.
Hypothesis: There will be a positive moderate correlation between pain intensity and
interference, and PTSD symptom severity using repeated patient-reported outcome
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measures. Pain intensity and interference point estimates will differ based on RA receipt
status, and on PTSD symptom trajectories throughout the course of RAMBPOS.
Rationale: This analysis of the RAMBPOS cohort is critical to understanding the effects
of PTSD symptom trajectories on pain following combat injury. Moreover, it is
imperative to utilize the possible relationship between PTSD trajectories and pain
outcomes as support for the value of integrating simultaneous care of either condition
across rehabilitation and recovery.
Chapter 4
Aim: Characterize probabilistic pain trajectories, stratified by those who did or did not
receive RA, after combat injury across multiple dimensions of pain intensity.
Hypothesis: Using a Markov model approach to examine pain trajectories, will illustrate
that participants receiving RA are less likely to transition to and less likely to remain in a
high pain intensity state over the two year model period compared to those not receiving
RA.
Rationale: By using patient-reported pain outcome measures to characterize pain
trajectories, it is possible to capture the multidimensional nature of pain after combat
injury while accounting for both time and pain management interventions. The
construction of probabilistic pain trajectories using transition matrices, stratified by RA
recipients, goes beyond simple linear numeric scales assessing temporal cross-sectional
pain experiences and captures the depth of pain presentations experienced after combat
injury.
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With the parent study’s data, this dissertation is an opportunity to understand the
association of pain and PTSD after injury, and consider the long-term benefits of
receiving early pain management through RA. The original aims of this dissertation are
unique from that of RAMBPOS, which only examined pain outcomes between
individuals who did or did not receive RA and did not consider mental health outcomes
or symptom trajectories. The aims of this dissertation and research protocol received
institutional review board (IRB) exempt status by the VA Medical Center Research &
Development Committee (Protocol #01685) and the University of Pennsylvania (Protocol
#827892).
This program of research is guided by The Biopsychosocial Model of Chronic Pain
(Figure 1-2).71 This model assumes the causes of, and health outcomes from, chronic
pain are affected by a magnitude of diverse social, physical, pathological, environmental,
and psychological factors in an individual’s life. Therefore, in order to adequately
manage chronic pain, all of these factors must be addressed by providers and caregivers
to the fullest extent possible. In this research, the model is used to place an injured
individual’s perception and response to pain in the context of the interrelationships
between biological changes from tissue trauma and psychological health, such as
PTSD.72 There is a shared pathophysiology between comorbid chronic pain and PTSD
that can be amplified when dysregulation in the peripheral processes (i.e. immune,
autonomic, endocrine) occurs in response to tissue trauma.73 Stress stimulated from
traumatic events, such as injury, increases dysregulation in the periphery processes that
heighten afferent feedback to the central processes in the model. For example, PTSD
14

associated neurotransmitters released from the inflammatory immune response go on to
potentially influence pain transmission and amplification along these pathways.
Behavioral reactions that result from changes in the central cognitive processes may
influence PTSD symptom presentations, alter patient-reported pain interference, and
exacerbate emotional responses. Pain driven emotions, such as feelings of vulnerability
or anger, that are also associated with PTSD interact and alter cognitive appraisals of
pain. Cognitions, in turn, attach meaning to the emotional experience and may activate
emotional responses and amplify the pain experience, propagating a cycle of nociception,
distress, and disability due to comorbid pain and PTSD.71,72,74 The social aspects of a
combat-injured individual’s life interact with both the physiological and psychological
aspects of injury to further modulate symptom severity. The severity of symptoms can
then perpetuate an injured-person’s ability to meet social and interpersonal relationship
expectations, independently complete activities of daily living, and navigate their
environment effectively. By adapting Engel’s generic biopsychosocial model of
disease,75 pain scientists have used the Biopsychosocial Model of Chronic Pain to
identify that:
“Research supports a strong bidirectional link between mood disorders and persistent
pain; the development of an enduring pain condition confers a substantially increased
risk for the subsequent diagnosis of an affective disorder, and psychosocial variables
such as depression, anxiety, and distress are among the most potent and robust
predictors of the transition from acute to chronic pain…efficacious analgesic
treatments that reduce the frequency and intensity of pain should have a beneficial
effect on patients’ affective states and appropriate treatment of emotional distress
should have a positive influence on the experience of pain.”76
However, in order to understand the development, co-occurrence, and contiunuation of
PTSD symptoms and pain requires this area of research to move beyond cross-sectional
15

descriptions of symptoms after injury. Further, research examining both conditions must
consider the effects of analgesic treatments, which can influence various aspects of the
biopsychosocial model in the efferent and afferent feedback between peripheral and
central processes. To do so requires the assessment of larger datasets measuring these
interrelated conditions, in order to further illuminate their interactions on one another. For
this reason, components of this dissertation consider how PTSD trajectories influence
pain intensity and interference, while also evaluating the effects of RA, which in turn
may improve acute pain and potentially influence the development of future chronic pain.
Significance
The ability to expand science in the use of early acute pain management with RA and
demonstrate its association with long-term health outcomes will be invaluable for future
trauma responders and clinicians managing acute pain after injury. The delivery of RA
after injury requires a coordinated effort among emergency responders, surgeons, nurses,
and trained anesthesia providers, such as Certified Registered Nurse Anesthetists
(CRNA).20,62 CRNAs are present in military, veteran, and civilian healthcare settings, and
therefore it is critical that CRNAs are trained to deliver effective pain management and
trauma care to the fullest extent of their scope of education and practice.77 Additionally,
timely and effective pain management is paramount to civilian, military, and veteran
populations. Studying short- and long-term benefits of early RA for combat trauma in this
dissertation has the potential to strengthen injury science and provide foundational
support to implementing CRNA led interventions after injury.

16

Understanding the short- and long-term health outcomes following serious injury is a
priority to both military and civilian agencies. This dissertation directly supports the
missions of many national organizations and their commitments to meeting the health
needs of the nation’s injured service members and civilians. The objectives of this
dissertation are well positioned with the National Institute of Nursing Research’s (NINR)
Strategic Plan to better manage symptoms of acute and chronic illnesses such as pain.78
NINR’s longstanding commitment to recognizing that pain can be a debilitating symptom
and chronic condition, furthers the significance in developing and testing effective CRNA
led pain management interventions, like RA. Similarly, the 2011 Institute of Medicine,
now known as the National Academy of Medicine, report called for a cultural
transformation in pain prevention, care, and research to be guided by the National
Institutes of Health led National Pain Strategy.79 The National Pain Strategy seeks to
promote research that benefits citizens most at risk of developing chronic pain and
promote the implementation of non-opiate interventions.80 The use of comprehensive
multimodal analgesics delivered via RA offers a low dosing, or opioid-sparing,
alternative for managing pain after serious injury. Research evaluating the effects of RA,
such as this dissertation, aligns with the 2016 Centers for Disease Control and Prevention
Guideline for Prescribing Opioids for Chronic Pain’s call for researchers to evaluate the
effectiveness of alternative non-opiate treatment options for pain.81 The findings of this
dissertation will further the knowledge needed to leverage advances in RA techniques in
order to promote best pain management practices, as put forth by the Army Surgeon
General’s 2010 Pain Management Task Force.82
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The health needs of combat injury survivors continue long after acute care, and
therefore healthcare providers must anticipate and evaluate changes in symptoms.
Findings from this dissertation emphasize that continued evaluation by clinicians and
researchers is required in this population, based on the complex presentations between
pain, PTSD, and depression after combat-related injury (Chapter 2). This dissertation
evaluates the long-term effects of RA, and the reciprocal influence of PTSD total
symptom severity trajectories, on patient-reported pain outcomes up to two years after
injury (Chapter 3). Moreover, innovative methodologies can be utilized to identify which
acute care interventions are most likely to be successful in changing the trajectory of
acute to chronic illnesses, and how interventions can influence the dynamics of pain
presentations (Chapter 4). Findings from this dissertation have the potential to inform
future trauma care planning, beginning from the time of acute care, in order to optimize
the health of traumatically injured persons throughout rehabilitation and recovery.
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Figure 1-1 Regional Anesthesia Military Battlefield Pain Outcomes Study (RAMBPOS) Schema
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Figure 1-2 The Biopsychosocial Model for Chronic Pain

A conceptual model of the psychosocial interactive processes involved in
health and illness.
Gatchel RJ. Comorbidity of chronic pain and mental health disorders: The
biopsychosocial perspective. American Psychologist. 2004;59(8):792-805
© American Psychological Association
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CHAPTER 2
Complexity of the Relationships of Pain, Posttraumatic Stress, and Depression in
Combat-Injured Populations: An Integrative Review to Inform Evidence-Based
Practice1

Abstract
Background
Understanding the complex interrelationships between combat injuries, physical
health, and mental health symptoms is critical to addressing the healthcare needs of
wounded military personnel and veterans. The relationship between injury characteristics,
pain, posttraumatic stress disorder (PTSD), and depression among combat-injured
military personnel is unique to modern conflicts and understudied in the nursing
literature.
Aim
This integrative review synthesizes clinical presentations and relationships of
combat injury, PTSD, depression, and pain in Operation Enduring Freedom (OEF) and
Operation Iraqi Freedom (OIF) United States military service members and veterans.
Methods
A literature search was conducted using relative key terms across databases to
identify peer-reviewed publications between 2001 and 2016 that examined health

1

The chapter is the author’s original work. A final version of this manuscript is published as NA Giordano, C Bader, TS Richmond,
RC Polomano. Worldviews Evid Based Nurs, 2018;15:2,113–126. © 2018 Sigma Theta Tau International, Wiley Periodicals, Inc. No
modifications are permitted without the permission of the copyright holder.
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outcomes of combat-injured persons in OEF and OIF. The quality of evidence was
evaluated and results synthesized to examine the association of combat injury as a risk
factor for PTSD, the relationship of PTSD and depression pre- and postinjury, and pain
management throughout care.
Results
Twenty-two articles were included in this review. Greater injury and pain severity
poses risks for developing PTSD following combat injury, while early symptom
management lessens risks for PTSD. Depression appears to be both a contributing risk
factor to postinjury PTSD, as well as a comorbidity.
Linking Evidence to Action
Findings demonstrate a compelling need for improvements in standardized
assessment of pain and mental health symptoms across transitions in care. This
integrative review informs nurse researchers and providers of the clinical characteristics
of pain, PTSD, and depression following combat injury and offers implications for future
research promoting optimal surveillance of symptoms.
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Introduction
Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) led to the
deployment of millions of United States military personnel. Over 50,000 troops serving
in OEF and OIF experienced combat injuries (Defense Casualty Analysis System, 2017).
Mechanisms of battlefield trauma have shifted to high-velocity weapons and improvised
explosive devices, capable of inflicting devastating injuries. Polytrauma describes
injuries to multiple organ systems and anatomical regions of the body, often due to blast
exposure. Polytrauma includes internal bleeding, major extremity injuries, traumatic
brain injuries (TBI), and other neurological injuries (United States Department of
Veterans Affairs, 2015). Advancements in military trauma care and evacuation
capabilities to higher levels of care have led to unprecedented increases in survival rates
and subsequently new patterns of complex healthcare needs of polytrauma survivors
(Clifford et al., 2014).
The polytrauma clinical triad, defined by pain, posttraumatic stress disorder (PTSD),
and TBI, is evident in over 40% of polytrauma OEF and OIF military service members
and veterans (Lew et al., 2009). High rates of mental disorders, such as depression,
coexist with this polytrauma clinical triad, further complicating the polytrauma
rehabilitative services required to address biopsychosocial healthcare needs postinjury
(Vyas et al., 2016). The concerning prevalence of depression seen in combat exposed
uninjured veterans (28%), compared to other mental health conditions, emphasizes the
importance of examining the interrelatedness of depression, PTSD, and pain after combat
injury (Thomas et al., 2010). Further, there is evidence that assessment and management
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of depressive symptoms, for all veterans, seeking care in primary care settings is an
effective suicide prevention approach (Denneson, Williams, Kaplan, McFarland, &
Dobscha, 2016).
This integrative review summarizes and analyzes the state-of-the-science pertaining to
the complex relationships of pain, PTSD, and depression experienced by combat-injured
OEF and OIF military service members and veterans. Because pain, PTSD, and
depression are present in the U.S. civilian trauma population, research from combatinjured military service members and veterans can inform civilian trauma care (National
Academies of Sciences, Engineering, and Medicine, 2016). Although TBI is part of the
polytrauma triad, this review only focuses on research addressing pain and mental health
outcomes associated with combat injuries, independent of neurological conditions. The
polytrauma literature continues to expand, however, there is still a paucity of studies
examining the interrelatedness of pain, PTSD, and depression associated with combat
injury. The purpose of this review is to evaluate and synthesize current research on the
influence of clinical injury characteristics related to the onset and persistence of pain,
PTSD, and depression symptoms in military personnel and veterans seeking care across
health settings.
Methods
Search Strategy
A targeted search of available literature, published between September 2001 and
December 2016, was conducted in PubMed, CINAHL, Scopus, and EMBASE, using the
following National Library of Medicine Medical Subject Headings terms and key words:
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adult (PubMed defines as >19 years); military personnel; veterans; veterans’ health; U.S.
Department of Veterans Affairs; Veterans Hospitals; wounds, injuries; penetrating
wounds; gunshot wounds; multiple trauma; pain; PTSD; and depression (Figure 2-1).
Combat injury refers to a sustained injury incurred in the line of duty because of armed
conflict (United States Department of Veterans Affairs, 2015). Search terms are available
online with this article.
Data Extraction
Studies retained for analysis met the following criteria: (a) samples included U.S.
military personnel or veterans who sustained combat injuries in the OEF and OIF wars;
(b) pain, PTSD, and depression were primary or secondary outcomes; (c) investigations
conducted in combat theater, military or Veterans Health Administration (VHA)
healthcare facilities; and, (d) secondary analyses of Department of Defense (DoD) or
VHA databases. Citations excluded were: (a) case studies, commentaries, expert
consensus reports, and editorials; (b) investigations of military or veteran populations
with TBI as a primary variable of interest; (c) studies not investigating combat-related
physical trauma or an outcome of interest (e.g., pain, PTSD, depression); (d) publications
prior to September 11, 2001; (e) non-English publications; and (f) investigations of
biomarkers, genomics, or imaging. Of the 1,848 database citations, 1,778 abstracts met
the criteria for inclusion, and 286 full text publications were evaluated applying exclusion
criteria. Twenty-two studies were deemed acceptable for this review (Figure 2-1).
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Data Analysis
Studies were evaluated for methodological quality, informational value, and
representativeness of combat-injured military personnel and veterans (Whittemore &
Knafl, 2005). The strength of evidence of each study was evaluated using Melnyk and
Fineout-Overholt's (2011) “Rating System for the Hierarchy of Evidence” (Level 1—
highest to Level 7—lowest). The strongest evidence to base clinical practice on is rated
Level 1 and includes both systematic reviews and meta-analyses of randomized
controlled trials. Level 2 refers to well-designed randomized control trials, whereas Level
3 evidence comes from controlled trials without randomization. Level 4 contains cohort
and case-control research studies. Level 5 evidence refers to systematic reviews of
descriptive and qualitative studies. Level 6 includes single descriptive studies and
qualitative work, and Level 7 refers to expert opinions. The integrative review process
included an analysis of samples across studies, data reduction, data display, data
comparison, conclusion drawing, and verification throughout the Results section, with
key findings synthesized and evidence rated in Table 2-1 (Whittemore & Knafl, 2005).
Results
The 22 studies included in this review were published in peer-reviewed journals and
comprised 10 retrospective analyses, four prospective observational studies, four
retrospective cohort studies, two cross-sectional descriptive studies, one descriptive
observational study, and one mixed-methods study.
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Samples, Data Sources, and Settings
Samples ranged from 50 to 191,747 participants in size, and were predominately
young (22–31 years, average age), Caucasian (46–95% of samples), and almost entirely
male (72–100% of samples). Sample data sources for retrospective studies were obtained
from the Combat Trauma Registry Expeditionary Medical Encounter Database and the
Joint Theater Trauma Registry, subsequently renamed DoD Trauma Registry, and
National VHA health records. Other studies were conducted at, or using data from,
military facilities (e.g., domestic and overseas, including a combat support hospital) and
within the VHA system. Variations in study settings and data sources, from time of
combat injury to rehabilitative care, provide a broad range of results capturing clinical
presentations postinjury.
Combat Injury: Risk Factor for PTSD
The incidence of PTSD varied within study samples, from 4.2% to 44%. The studies
in this integrative review utilized clinician diagnoses, both ICD-9 codes and medical
records, as well as self-report measures, such as the PTSD patient checklist (PCL) scored
using the diagnostic criteria based on Diagnostic and Statistical Manual IV-TR (DSMIV). Combat injury was found to be a significant risk factor for developing PTSD. Baker
et al. (2009) established that injury during combat was significantly related to a positive
PTSD screening among combat-injured veterans compared to those without injuries
(odds ratio [OR], 3.14; 95% confidence interval [CI] [1.73, 5.71]). Despite the crosssectional approach and self-report of physical combat injury status, which resulted in a
low quality of evidence (Level 6), Baker et al. provide support of the association between
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injury status and PTSD. Using the PCL, Phillips, LeardMann, Gumbs, and Smith (2010)
found that individuals who experienced gunshot wounds or serious injury in combat were
more likely to develop postdeployment PTSD compared to those without similar trauma
(OR, 3.51; 95% CI [1.58, 7.77]). Phillips et al. provide stronger support for this
relationship (Level 4), largely due to the prospective nature of the study. In addition,
higher injury severity scores (ISS) were identified as a key variable for developing PTSD
among military personnel. Initial findings by MacGregor, Corson et al. (2009) and
MacGregor, Shaffer et al. (2009) suggested that combat-injured military personnel
experienced higher rates of PTSD compared to uninjured peers. MacGregor, Tang,
Dougherty, and Galarneau (2013) found that after adjusting for ISS, those injured in
combat were twice as likely to develop PTSD compared to noncombat-injured military
personnel (OR, 2.10; 95% CI [1.60, 2.75]).
ISS is used to evaluate anatomic injury and severity ranging from 0 to 75, with 75
indicating the greatest severity of injuries (Baker, O'Neill, Haddon, & Long, 1974).
Combat-injured military personnel with, what MacGregor et al. (2013) defined as, an ISS
of moderate (4–8) and serious-severe (9+) had significantly increased odds of developing
PTSD (OR, 1.49; 95% CI [1.11, 2.00]) compared to those with mild (1–3) ISS (OR, 1.64;
95% CI [1.01, 2.68]). Prior combat injury was also predictive of PTSD (OR, 1.96; 95%
CI [1.22, 3.16]). Sandweiss et al. (2011) recognized that within the Millennium Cohort
combat-injured population, a 3-unit increase in ISS translated to 16% increased likelihood
of developing postdeployment PTSD symptoms (OR, 1.16; 95% CI [1.01, 1.34]). This
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summates to a clear connection between combat injury, injury severity, and subsequent
development of PTSD, relative to noncombat-injured military personnel.
Researchers identified an association between injury mechanism and PTSD.
Investigators at a polytrauma rehabilitation center observed veterans with combat blastrelated injuries had significantly higher rates of PTSD (45.1% of sample) compared to
those with noncombat-related injuries (2.1%) or injuries without blast exposure (11.8%, p
< .001; Clark, Walker, Gironda, & Scholten, 2009). McLay, Webb-Murphy, Hammer,
Volkert, and Klam (2012) reported veterans experiencing both blunt and penetrating
combat injuries, had significantly higher rates of PTSD symptoms compared to those
with no injuries or solely penetrating trauma (p < .05). In addition, Mora et al. (2009),
identified that within their sample of burned combat-injured military personnel,
individuals exposed to blast were more likely to screen positive for PTSD than those
without blast injuries (OR, 3.27; 95% CI [1.17, 9.16]). This sample of severely burned
military personnel exhibits that PTSD symptoms can potentially be a function of type,
severity, and mechanism of injury. The increased odds of PTSD, from combat injury,
further compounded by severity, indicates polytrauma may influence mental health
outcomes. Not all studies included in this review measured PTSD severity, and many
only reported the presence of PTSD, which limited the ability to examine severity of
PTSD with injury severity.
Depression and PTSD
Depression rates within studies targeted for this review ranged from 7% to 27%, and
were measured using self-reported measures or ICD-9 codes. The coexistence of PTSD
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and depression in combat-injured service members is complex, and some researchers
contend that previous mental health diagnoses act as precursors to the development of
PTSD. Sandweiss et al. (2011) identified that a preinjury mental disorder, including
depression, was a risk factor for developing PTSD. Researchers screening for PTSD
symptoms found those with one or more mental disorder at baseline had 2.52 times (95%
CI [2.01, 3.16]) greater risk for postdeployment PTSD after injury. The prospective
approach, employed by Sandweiss et al., provides a unique opportunity to examine
depression prior to injury and offers strong evidence to support this predisposing
relationship (Level 4). Similarly, MacGregor et al. (2013) documented that a mental
health diagnosis within 1 year prior to deployment increased odds of developing PTSD
following injury (OR, 2.69; 95% CI [1.50, 4.81]; Level 4).
Although the aforementioned studies support a higher likelihood for PTSD with an
existing mental disorder prior to combat injury, others purport that there is a bidirectional
relationship between PTSD and depression. Several researchers identify depression as
being a common mental disorder appearing with PTSD following trauma. Clark, Bair,
Buckenmaier, Gironda, and Walker (2007) found PTSD evident in 44% and depressive
disorders in 24% of their sample. Researchers following combat-injured military
personnel transitioning from DoD to VHA care reported similar rates, for PTSD (38%)
and depression (27%; Copeland et al., 2011). Similar work by Clark et al. (2009)
identified elevated rates of PTSD and depression among polytrauma care seeking
veterans who experienced combat blast related injuries (45.1%, 25.5%, respectively)
compared to their noncombat-injured (2.3%, 7.0%) and combat-injured without blast
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exposure (11.8%, 14.7%). VHA researchers report that in a sample of veterans, those
injured in combat with a PTSD diagnosis were significantly more likely to also meet
depression criteria compared to those uninjured (p < .001; Baker et al., 2009). However,
the relationship, whether causal-effect or bidirectional, could not be determined due to
the cross-sectional nature of these studies (Level 6). Within a national sample of OEF and
OIF veterans seeking care, Pugh et al. (2014) identified that depression was a significant
comorbidity with PTSD for polytrauma veterans. Veterans presenting with “comorbidity
clusters,” defined by the presence of polytrauma, PTSD, and depression were most likely
to have adverse outcomes, as evidenced by the high likelihood of emergency care,
compared to individuals in “comorbidity clusters” without both PTSD and depression
(OR, 3.90; 95% CI [3.70, 4.10]). Pugh et al. (2014) claim that depression is a central
comorbidity that contributes substantially to healthcare utilization and adverse outcomes
for veterans. Pugh et al.’s large sample size (N = 191,797) strengthens support for this
relationship (Level 4); however, this study fails to account for time since injury or
symptom severity.
The presence of PTSD and depression across VHA facilities, among combat-injured
service members, demonstrates a need to investigate the interplay these two illnesses
have on long-term health outcomes. Grieger et al. (2006) showed that early significant
somatic symptom severity from combat injuries, as measured by the self-reported 15-item
Patient Health Questionnaire, was associated with PTSD and depression diagnoses 7
months postinjury. In a combat-injured cohort, individuals with high somatic symptom
scores (≥8, 0–26 scale) 1 month after combat injury had higher rates of mental health
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diagnoses when compared to their less symptomatic peers (<8). Individuals with higher
somatic symptom severity 1 month after injury were more likely to develop PTSD (OR,
9.10; 95% CI [4.10, 20.10]) and depression (OR, 5.70; 95% CI [2.40, 13.20]) 7 months
later. These prospective findings by Grieger et al. provide evidence (Level 4) to support
that initial symptom severity can potentially predict the development of mental health
symptoms.
Pain and PTSD
Researchers examined pain severity, both immediately postinjury and throughout
rehabilitation, and the potential role of pain management interventions in the
development of PTSD. Holbrook, Galarneau, Dye, Quinn, and Dougherty (2010)
established that morphine-based pain management, immediately following combat
injuries, exerted a protective effect on the development of PTSD up to 2 years postinjury
(OR, 0.47; 95% CI [0.34, 0.66]). Melcer et al. (2014) confirm the success of early pain
management with morphine, over other medications, in reducing odds of developing
PTSD up to 4 years after injury (OR, 0.40; 95% CI [0.17, 0.94]). Further, McGhee,
Maani, Garza, Gaylord, and Black (2008) and McGhee et al. (2014) reported a lower
prevalence of PTSD among injured service members who received ketamine during their
surgeries compared to those who did not (p = .044). Findings from Buckenmaier et al.
(2009) show early benefits of aggressive pain management include the reduced
symptoms of anxiety and distress correlating with pain relief. These studies provide
evidence for early effective pain control to reduce the development of PTSD and reduce
early symptom severity.
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Investigators evaluated pain and mental health symptoms long after initial injury.
Stratton et al. (2014) revealed that baseline pain severity accurately predicted latent
PTSD diagnoses, and PTSD severity predicted pain severity at 1-year follow-up (χ2 =
3.66; p < .05). This prospective study design offers evidence to support this association
(Level 4). In polytrauma rehabilitative centers, researchers identified pervasive needs for
the treatment of co-occurring pain and stress disorders, such as PTSD (Clark et al., 2007,
2009; Sayer et al., 2009). Pugh et al.’s (2014) analysis of “comorbidity clusters”
concluded that pain demonstrated no consistent pattern in predicting adverse outcomes,
unless comorbid with depression and PTSD. Individuals with all three comorbidities had
the highest odds of adverse outcomes, such as homelessness (OR, 6.60; 95% CI [5.80,
7.50]) and suicide-related behaviors (OR, 13.30; 95% CI [10.30, 17.20]) than other
polytrauma cohorts. Adequate pain management after injury potentially influences PTSD
symptoms across healthcare settings.
Discussion
This integrative review examines the complex relationship between pain, PTSD, and
depression, seen in combat-injured OEF and OIF military personnel. Findings underscore
the importance of assessing for potential comorbidities after combat injury. The postSeptember 11, 2001 veteran population is projected to increase 46% by 2019, and while
the VHA cares for millions of veterans, almost half seek care in civilian healthcare
facilities (National Center for Veterans Analysis and Statistics, 2016). Nurses practicing
in military healthcare facilities encounter service members and veterans injured in OEF
and OIF. Because these nurses deliver care across all transitions of care from Level 1, at
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the point of injury, to Level 5, at U.S. major military facilities, it is critical that they
understand the consequences of combat injuries on physical and mental health (Bagg,
Covey, & Powell, 2006). VHA and civilian nurses are also likely to care for veterans who
sustained combat trauma, and they too must combine scientific knowledge,
interdisciplinary collaboration, and patient and family advocacy to improve patient
outcomes. Early recognition of trauma-related pain, PTSD, and depression, and
interventions aimed at reducing their severity are essential to combat casualty and trauma
care. Nurse Practitioners and Certified Registered Nurse Anesthetists are also practicing
in military, veteran, and civilian trauma care settings and are positioned to assume
responsibilities for the management of combat-injury related pain (Schoneboom et al.,
2016).
Mental Health
There is an established association between combat exposure and mental health,
particularly PTSD (Hoge, Riviere, Wilk, Herrell, & Weathers, 2014). However, the
causal relationship between combat injury and subsequent development of PTSD is not
clear. Numerous factors contribute to the preinjury, acute injury, and postinjury stages
that can influence the development of PTSD among combat-injured military personnel.
Several studies demonstrate the need to screen and identify predeployment risk factors,
such as mental disorders and previous traumatic exposures. Researchers identified
associations between injury severity (Baker et al., 2009; MacGregor, Corson et al., 2009;
MacGregor, Shaffer et al., 2009; MacGregor et al., 2013; Sandweiss et al., 2011) and
pain management in developing PTSD postinjury (Holbrook et al., 2010; McGhee et al.,
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2008; McGhee et al., 2014; Melcer et al., 2014). Mechanistic type of injury, particularly
blast or in combination with blunt and penetrating trauma, can influence the development
of postinjury mental health symptoms (e.g., PTSD and depression; Clark et al., 2009;
McLay et al., 2012; Mora et al., 2009; Pugh et al., 2014). Risk of developing PTSD is
higher in those experiencing combat-related trauma, compared to individuals with
noncombat-related injuries, and risk increases with injury severity (MacGregor, Corson et
al., 2009; MacGregor, Shaffer et al., 2009; Sandweiss et al., 2011).
Several studies address the presence of depression preceding combat injury and
subsequent development of PTSD (Clark et al., 2007; MacGregor et al., 2013; Sandweiss
et al., 2011). Others described comorbid depression and PTSD following injury (Clark et
al., 2009; Grieger et al., 2006). In civilian populations, individuals with comorbid PTSD
and depression may experience more severe depression, increased healthcare cost, and
lower physical functioning than individuals with either condition alone (Campbell et al.,
2007). The foundation of research examining PTSD and depression symptoms as
comorbidities highlights the need for further analysis of these relationships in combatinjured populations.
Pain in the Context of Combat Injury Care
Pain is one of the most frequently reported symptoms after combat injury. Pain
management, in addition to alleviating postinjury acute pain, can reduce symptom
severity of other physical and mental symptoms caused by trauma (Clark et al., 2007).
Acute pain can be substantial when considering the extent of injury polytrauma entails.
Moreover, combat-injured veterans may experience chronic pain. Chronic pain may
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cause irritability, social withdrawal, depressed mood, sleep changes, and lead to
disruption in social relationships (Katz & Rothenberg, 2005). VHA investigators report
over one third of polytrauma survivors experience multiple types of chronic pain (e.g.,
neuropathic, phantom limb), and over two thirds of combat-injured veterans need pain
management interventions throughout polytrauma rehabilitation (Clark et al., 2007, 2009;
Copeland et al., 2011; Sayer et al., 2009). The prevalence of chronic pain and continued
pain management needs in this population further emphasizes the urgency for early acute
pain management.
Early pain interventions may mitigate the lasting effects of acute trauma that lead to
the development of chronic pain by interrupting the cascade of events triggering
neurotransmitter release, intracellular responses, and neuropsychological response. For
example, Buckenmaier et al. (2009) and Buckenmaier, Mahoney, Anton, Kwon, and
Polomano (2012) found that incorporating aggressive multimodal regional analgesia after
injury significantly reduced pain intensity in combat-injured soldiers compared to
soldiers receiving standard pain management. Clinical characteristics of injury (e.g.,
severity and mechanism) are associated with the risk of developing postinjury PTSD and
depression (Grieger et al., 2006), as well as acute and chronic pain. A significant, but
weak, relationship exists between ISS and acute pain severity (Fowler et al., 2011), and
injury type (e.g., blast), which may interfere with pain relief (Clark et al., 2009). Given
the disabling effects of undermanaged mental health conditions and comorbid chronic
pain, early assessment and management of polytrauma related symptoms are critical. A
previous study documents that injured OEF and OIF veterans with comorbid PTSD and
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chronic pain experienced greater pain-related disability than veterans with chronic pain
alone. However, the study sample did not include combat-injured veterans. OEF and OIF
veterans with comorbid PTSD and chronic pain experienced greater pain-related
disability than veterans with chronic pain alone (Outcalt et al., 2015). Unlike previous
polytrauma reviews (Dobscha et al., 2009), this review highlights the multidimensional
clinical presentations of pain in relation to depression and PTSD.
Limitations
There are limitations to the research included in this review. First, the literature has
no unified means of measuring PTSD, depression, and pain postinjury, or even injury
itself. Researchers utilized the ISS, however many relied on self-reported injury status.
PTSD screening tools varied, with some using clinician diagnoses and others patient selfreports. Updated PTSD diagnostic criteria in the DSM-5 may limit the ability to
understand the predictive factors leading to positive screenings of PTSD among military
populations. However, researchers have demonstrated the consistency between DSM-IV
and DSM-5 criteria within U.S. veterans (Miller et al., 2013). This affirms a consistency,
at least in veteran populations, for PTSD assessments and the ability to compare previous
studies to future work. Second, study designs affect overall generalizability and quality of
findings. The few prospective studies and numerous retrospective studies, which the
applied criteria consider to be of lower evidence quality, speak to the difficulties in
conducting research investigating combat-injured populations. The inherent limitations of
retrospective studies hinder the ability to identify causal relationships. Finally, small
sample sizes and high attrition rates limit the ability to draw definitive conclusions about
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the care of all combat-injured persons. For instance, Grieger et al. (2006) and Stratton et
al. (2014) experienced attrition rates of 40% and 47%, respectively. This review
demonstrates the necessity of understanding risk factors that complicate the relationship
between pain and mental health, postinjury.
Future Directions
Improved survival rates after polytrauma warrant a need for more prospective
longitudinal studies to capture these unprecedented symptom trajectories. The inclusion
of comprehensive standard assessment measures is vital to optimizing the care of combatinjured persons and determining predictors of long-term health outcomes. Currently,
initial trauma measures are valuable clinical tools, but not comprehensive to
understanding long-term symptom trajectories. Several articles identified the value initial
traumas measures, specifically ISS, can have in identifying individuals at risk of
developing PTSD, however, civilian researchers have found that increasing objective
injury severity is not directly related to the development of PTSD (Richmond et al.,
2011). The integration of uniform health screening metrics in the recent Pain Assessment
Screening Tool and Outcomes Registry (PASTOR), developed by the Pain Management
Task Force, addresses the use of standardized measures for research and clinical care
(Cook, Buckenmaier, & Gershon, 2014). PASTOR incorporates the National Institutes of
Health's Patient-Reported Outcomes Measurement Information System (PROMIS®)
Measures. For example, the Defense and Veterans Pain Rating Scale (DVPRS) has
already undergone testing in military and VHA facilities (Polomano et al., 2016).
PASTOR provides much-needed standardization of patient-reported outcome measures
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for assessment across all transitions of care, phases of recovery, and reintegration into
civilian life. Nurses are in a unique position to implement assessment measures and
incorporate standardized measures in their clinical and research practices.
Conclusions
This integrative review examined the complex clinical presentations and
interrelationships of pain, PTSD, and depression experienced by combat-injured military
personnel and veterans. Injury severity is a contributing factor to the development of
PTSD following combat injury among OEF and OIF military personnel and veterans.
Pain severity and early symptom management influence the development of PTSD
following combat injury. Depression appears to be both a contributing risk factor to
postinjury PTSD, as well as a comorbidity. Pain remains a major concern for polytrauma
survivors long after the initial injury. This paper contributes an analysis of empirical
research that specifically examines the relationship among PTSD, depression, and pain
outcomes for military personnel not only exposed to combat but also those injured
serving our nation.
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Figure 2-1: PRISMA Flow Diagram
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Table 2-1: Summary of Studies
Citation

Objective

Sample (setting)

Study design

Relevant findings

Relationships of key outcomes of
interest

Quality of
evidence a

Baker et al.
(2009)

Examine relationship
between demographic
factors, military service,
combat-related injury, and
mental health symptoms

N = 339
OEF/OIF veterans
(VHA)

Cross-sectional

Those who endorsed being
injured during combat were
more likely to screen positive
for PTSD compared to those
with no injuries
About 37% of the sample
screened positive for PTSD
and about 43% reported
having depressed mood within
the previous month

The prevalence of disease
burden and severity for both
depressive mood and PTSD is
higher in those with combat
injuries, potentially comorbid in
nature

Level 6

Buckenmaier
et al. (2009)

Evaluate pain severity and
emotional status of injured
soldiers

N = 110
OEF/OIF soldiers
(Landstuhl Regional
Medical Center,
Germany)

Mixed methods

Average and worst pain scores
were negatively correlated to
pain relief during transport
Average pain relief in 24–48
hr after injury was less than
50% but those with a
continuous peripheral nerve
block reported better pain
relief than those without one

Higher pain intensity scores
correlate with higher anxiety,
distress, and worry during
transport and may be of
consideration for how pain
management can influence early
symptoms of mental health
conditions

Level 6

Buckenmaier
et al. (2012)

Quantify patient-reported
pain outcomes following
acute pain service
interventions

N = 71
OEF/OIF soldiers
(Camp Bastion,
Afghanistan)

Descriptive
observational

Patients receiving peripheral
nerve block reported better
overall pain control compared
to those receiving epidural or
systematic analgesia
The analgesic interventions
implemented by acute pain
service reduced patientreported pain severity over the
first 24 hr following combat
injury

Overall mean percent reduction
in pain intensity from time after
initial injury to postacute pain
service interventions prior to air
evacuation was 60%, thereby
indicating adequate acute pain
assessment and management are
feasible after injury

Level 6

Clark et al.
(2007)

Describe innovative
approaches for improving
pain care provided to
OEF/OIF military personnel

N = 50
OEF/OIF soldiers
and veterans
(Polytrauma
Rehabilitation
Center)

Cross-sectional

Regional anesthesia and
continuous peripheral nerve
block are most often used to
manage pain after combat
injury
Common mental health
concerns for polytrauma

The comorbid presentations of
pain, PTSD, and depression are
seen in polytrauma care settings
in high proportions

Level 6
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Table 2-1: Summary of Studies
Citation

Objective

Sample (setting)

Study design

Relevant findings

Relationships of key outcomes of
interest

Quality of
evidence a

service members are PTSD,
adjustment disorder, and
depression in this sample
Clark et al.
(2009)

Compare physical and
emotional treatment
outcomes of service
members who sustained
polytrauma injuries
secondary to blast exposure
compared to soldiers injured
by other mechanisms

N = 128
OEF/OIF soldiers
and veterans
(Polytrauma
Rehabilitation
Center)

Retrospective
analysis

PTSD was significantly more
common among combat/blast
injured cohort
Functional independence
measure scores were
correlated to pain intensity
scores for combat/blast
injuries
Those with combat/blast
injuries had higher rates of
PTSD, and any psychiatric
diagnosis
Combat-/blast-injured
personnel experience
significantly less improvement
in pain severity

Injury mechanism, specifically
blast, is associated with a
broader spectrum of injuries,
reduced improvements in pain
intensity after treatment, and
higher rates of psychiatric
disorders

Level 4

Copeland et al.
(2011)

Assess care transitions from
DoD to VHA care and
subsequent psychiatric care
of combat-injured OEF/OIF
veterans

N = 216
OEF/OIF veterans
(VHA)

Retrospective
cohort

In the sample, 38% sought
care for PTSD symptoms and
27% for depression in the
VHA, whereas in Department
of Defense care, only 21%
received a mental health
diagnosis of any kind
In the VHA setting, 65% of
sample received pain
medication

The coexistence of PTSD, pain,
and depression in combat-injured
veterans seeking VHA care
suggests a delay in development
or recognition of these trauma
symptoms

Level 4

Fowler et al.
(2011)

Examine the relationship of
pain, injury, severity, and
physiologic response in
combat-injured soldiers

N = 2,646
OEF/OIF military
personnel
(JTTR)

Retrospective
analysis

Pain scores were not related to
physiologic parameters
ISS was proportional to the
pain experienced of wounded
soldiers

Increasing ISS maybe
proportional to pain scale
responses in wounded soldiers
but not for physiological
responses to acute injury related
stress

Level 6
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Table 2-1: Summary of Studies
Citation

Study design

Quality of
evidence a

Sample (setting)

Grieger et al.
(2006)

Examine rates, predictors,
and course of PTSD and
depression among seriously
injured soldiers following
hospitalization

N = 243
OEF/OIF soldiers
(Walter Reed Army
Medical Center,
Maryland)

Prospective
observational

High severity of physical
problems at 1-month
postinjury was significantly
associated with a diagnosis of
PTSD and depression over
time
Majority of participants with
PTSD or depression at end of
follow-up period (7 months)
did not qualify for an initial
diagnosis at 1 month after
injury

Early severity of physical
combat injuries, including pain
severity, is strongly associated
with the latent development of
PTSD or depression

Level 4

Holbrook et al.
(2010)

Study effect of morphine
use during early
resuscitation on developing
PTSD in injured military
personnel

N = 653
OIF soldiers
(CTR EMED)

Retrospective
cohort

The use of morphine 24 hr
after injury was significantly
associated with reduced risk of
PTSD compared to those who
did not receive morphine

Aggressive pain management in
the immediate postacute injury
period, specifically the use of
morphine, is strongly associated
with lower risk of PTSD

Level 4

MacGregor et al.
(2009)

Characterize the relationship
between injury-related
factors and PTSD among
battle-injured military
personnel

N = 831
OIF military
personnel
(CTR EMED)

Retrospective
analysis

As ISS increases, the odds of
being diagnosed with a mental
health illnesses increases
Serious and severe ISS scores
increased the odds of being
diagnosed with PTSD

Injury severity may be a
significant predictor of PTSD
and other mental health
diagnoses, including depression
up to 6 months after initial injury

Level 4

MacGregor et al.
(2009)

Describe prevalence of
PTSD and self-reported
mental health symptoms
among OIF combatants

N = 1,968
OIF military
personnel
(CTR EMED)

Retrospective
analysis

Greater risk for PTSD and
other mental health diagnoses,
including depression, among
battle-injured than nonbattleinjured
Injury severity indicated
greater risk for developing
PTSD or other mental health
diagnoses

Compared with nonbattle
injuries, those with battle
injuries had a greater risk of
PTSD and other mental health
diagnosis, such as depression,
and there was a positive
association with injury severity
possibly resulting from the
mechanisms of battlefieldrelated injuries

Level 4

MacGregor et al.
(2013)

Examine the association
between deployment-related
injury and PTSD among

N = 3,403
OIF military
personnel

Retrospective
analysis

Predictors of PTSD among
those with battle injuries
included moderate to serious-

The presence of mental health
conditions, such as depression,
may act as predisposing risk

Level 4
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Relevant findings

Relationships of key outcomes of
interest

Objective

Table 2-1: Summary of Studies
Citation

Objective

Sample (setting)

battle-injured and nonbattleinjured personnel

(CTR EMED)

McGhee et al.
(2008)

Investigate the prevalence
of PTSD in OEF/OIF
service members treated for
burns and administered
perioperative ketamine

N = 147
Soldiers sustaining
burns
(JTTR)

McGhee et al.
(2014)

Evaluate relationship
between early acute pain
scores and PTSD in burned
soldiers

McLay et al.
(2012)

Melcer et al.
(2014)

Study design

Relevant findings

Relationships of key outcomes of
interest

Quality of
evidence a

severe ISS, prior battle injury,
and mental health diagnosis
within 1 year predeployment
Battle injury is a significant
predictor of PTSD compared
to those not injured in battle

factors for PTSD after
experiencing serious-severe
combat injuries

Retrospective
cohort

The prevalence of PTSD was
lower among those receiving
ketamine compared to those
who did not receive ketamine

Pharmacological pain
management interventions,
specifically the use of ketamine
after combat-related burn
injuries, may act as a protective
factor in developing PTSD

Level 4

N = 289
Soldiers sustaining
burns
(JTTR)

Retrospective
analysis

Despite increased ISS in
combat injuries, individuals
exposed to ketamine
experienced no greater risk of
developing PTSD as less
severely injured soldiers
without ketamine

Decreased PTSD development
may be related to effective pain
control, specifically the use of
ketamine after burn injuries

Level 6

Determine whether different
injury mechanisms predict
the risk and severity of
PTSD symptoms

N = 1,402
OEF/OIF military
service members
(Naval Medical
Center, San Diego)

Retrospective
analysis

Service members with blunt
and combined (e.g., blunt and
blast) mechanisms of injury
had higher symptom severity
of PTSD than those with no
injury or only penetrating
injures

Mechanism of combat injuries
(blunt trauma and blast
exposure) is associated with high
rates of PTSD.

Level 6

Examine short-term and
long-term psychological
outcomes among combat
amputees

N = 145
OEF/OIF veterans
(CTR EMED)

Retrospective
analysis

Significantly reduced odds of
PTSD among amputees
receiving intravenous
morphine compared to
fentanyl over 4 years
postinjury
PTSD prevalence increased
after first-year postinjury
while rates of other

The adequate management of
acute pain with morphine has
shown a potentially protective
effect, compared to fentanyl, on
subsequent development of
PTSD after combat-injured limb
amputation

Level 4
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Table 2-1: Summary of Studies
Citation

Objective

Sample (setting)

Study design

Relevant findings

Relationships of key outcomes of
interest

Quality of
evidence a

psychological illnesses
decreased
Mora et al. (2009)

Examine the association
between primary blast
injuries and PTSD in burned
combat casualties

N = 333
OEF/OIF Soldiers
(JTTR)

Retrospective
analysis

IED wounded participants
with burns and blast related
injuries had increased odds of
having a PTSD diagnosis
compared to those with just
blast injuries

Risk of developing PTSD is a
function of injury type, severity,
and mechanism of injury (e.g.,
blast)

Level 6

Phillips et al.
(2010)

Explore the relationship
between specific combat
exposures and other life
experiences with
postdeployment PTSD

N = 706
Marines
(Marine Corps
Recruit Depot in
San Diego,
California)

Prospective
observational

Marines with gunshot wounds
or serious wounds were more
likely to screen positive for
PTSD compared to those who
had neither

Rates of mental health morbidity
among marines is due in part to
the increased risk of PTSD
associated with severe combat
injury as well as individuals’
traumatic psychological
exposures, such as violence,
prior to deployment

Level 4

Pugh et al. (2014)

Identify comorbidity
clusters among veterans
seeking care for
deployment-specific
diagnoses, including combat
injuries

N = 191,797
OEF/OIF veterans
in
(VHA)

Retrospective
cohort

Six clusters were identified:
(a) PCT, depression, chronic
disease; (b) PCT; (c) mental
health and substance abuse;
(d) sleep, amputation, chronic
disease; (e) pain and moderate
PTSD; (f) relatively healthy
Depression was a significant
comorbidity and characterized
by PTSD when present in
cluster A and C and
individuals were most likely to
have adverse outcomes and
healthcare utilization

The comorbid nature of
depression, PTSD, and pain
compounds in veterans seeking
care in the VHA as evident in
increased complexity of care
needs and care utilization

Level 4

Sandweiss et al.
(2011)

Prospectively assess the
relationship of
predeployment psychiatric
status, injury severity, and
postdeployment PTSD

N = 22,630
Service member
participants in the
Millennium Cohort
Study

Prospective
observational

After adjusting for baseline
PTSD and all other exposure
variables, the odds of
postdeployment PTSD
symptoms were greater in
those with one or more

Diagnosed mental health
conditions, including depression,
potentially act as predisposing
risk factors for PTSD following
combat injury

Level 4
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Table 2-1: Summary of Studies
Citation

Objective

Sample (setting)

Study design

(Naval Health
Research Center in
San Diego,
California)

Relevant findings

Relationships of key outcomes of
interest

Quality of
evidence a

defined baseline psychiatric
disorders compared to those
with no psychiatric disorders
After adjusting for baseline
PTSD symptoms, the odds of
postdeployment PTSD
symptoms were 16% greater
for every 3-unit increase in
ISS

Sayer et al.
(2009)

Describe the medical
rehabilitation needs of
OEF/OIF inpatients with
combat injuries

N = 188
Military personnel
and veterans
(Polytrauma
Rehabilitation
Center)

Retrospective
analysis

Pain and psychiatric
symptoms were significant
complaint during inpatient
stay and all patients received
pain management
interventions
Pain was present in 100% of
the sample and at 50%
experienced mental health
symptoms

Pain is pervasive in veterans
following polytrauma and
requires optimal management so
as to prevent interference in
physical and psychological
rehabilitation efforts

Level 6

Stratton et al.
(2014)

Investigate the longitudinal
course of pain and PTSD
symptoms following blast
exposure

N = 209
OEF/OIF Military
personnel
(VHA)

Prospective
observational

PTSD scores and symptoms
exert a strong influence on
pain scores
PTSD scores at baseline
predict patient-reported pain
scores at 6 and 12 months,
whereas baseline pain scores
only predict PTSD scores at 6
months

Pain and PTSD are significantly
associated with one another
across the care continuum when
present indicating optimal
management early on after
diagnosis can influence
symptom severity longitudinally

Level 4

Note. PTSD, posttraumatic stress disorder; IED, improvised explosive device; ISS, Injury Severity Score; PCL-M, PTSD checklist military version; OEF/OIF, Operation Enduring Freedom/Operation
Iraqi Freedom; VHA, Veterans Health Administration; CTR EMED, Combat Trauma Registry Expeditionary Medical Encounter Database; JTTR, Joint Theater Trauma Registry.
a
Level of evidence determined using rating system for the hierarchy of evidence (Melnyk & Fineout-Overholt, 2011). The hierarchy is a seven-tier scale, with the best evidence receiving the strongest
rating. The strongest evidence to base clinical practice on is rated Level 1 and includes both systematic reviews and meta-analyses of randomized controlled trials or evidenced-based clinical practice
guidelines based on systematic reviews of randomized controlled trials. Level 2 comprises evidence from well-designed randomized control trials, Level 3 evidence comes from controlled trials with no
randomization. Level 4 contains cohort and case-control research studies. Level 5 evidence is produced from systematic reviews of descriptive and qualitative studies. Level 6 includes both single
descriptive studies and qualitative work, and the weakest evidence, Level 7, is expert opinions.
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CHAPTER 3
Longitudinal Trajectories of Pain and Post-Traumatic Stress Symptoms After
Exposure to Regional Anesthesia Following Combat Injury
Abstract
Unrelieved acute pain after combat injury can contribute to the development of chronic
pain and post-traumatic stress disorder (PTSD). There are few studies evaluating
longitudinal presentations of pain and PTSD symptoms after combat-injured patients
receive acute pain management. This prospective observational cohort study evaluated
the association of early pain management and PTSD symptom trajectories on pain
experiences in 288 Operation Enduring Freedom and Operation Iraqi Freedom
(OEF/OIF) combat-injured military personnel who received regional anesthesia (RA) or
standard pain management approaches for pain management. Pain and PTSD symptoms
are moderately to strongly (rs > .31) positively correlated up to 21 months after injury (P
< .05). Linear mixed effects models indicate that both initial pain intensity (P < .001) and
initial PTSD symptom severity are strongly associated with pain intensity and
interference (P < .001). Moreover, worsening PTSD symptom trajectories are
significantly associated with higher average pain and pain right now, after controlling for
injury severity, RA receipt, and time from injury to observation (P < .02). There are
short- and long-term reductions in pain intensity with early RA administration following
combat injury (P < .01). Evidence indicates that RA is an effective intervention and that
both pain and PTSD symptoms should be evaluated and addressed on an ongoing basis in
combat-injured persons.
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regional anesthesia, combat injury, Operation Enduring Freedom (OEF), Operation Iraqi
Freedom (OIF)

57

Introduction
Significant advancements in combat casualty care have increased survival rates in
American military personnel sustaining complex combat injuries during Operation
Enduring Freedom and Operation Iraqi Freedom (OEF/OIF).1,2 The severity of many of
these combat related-injuries warrant early and sustained pain management. However,
acute pain services delivered by pain management specialists capable of providing early
multimodal analgesics in the immediate aftermath of injury and throughout the military
evacuation chain are still needed as part of the combat casualty care.3,4 Evidence suggests
that hyperstimulation of central neuronal pathways and unrelieved acute pain induces
neural plasticity in the central nervous system and leads to maladaptive neuropathological
remodeling after injury.5,6 This rewiring may result in chronic pain and elevate
subsequent risk for mental health conditions, such as post-traumatic stress disorder
(PTSD), for patients who have experienced unrelieved severe pain after traumatic
injury.7-9 To date, there have been few longitudinal studies of this association after
combat-related injury.
Chronic pain and PTSD are believed to share a vulnerability pathway that, when coexisting, amplify exacerbations of symptoms, increase pain intensity, and pain
interference.10-13 Pain intensity is a valuable measure of how severe pain is, and pain
interference is a measure of how pain impacts physical, social, and emotional
functioning.14 Severe persistent PTSD symptoms, lasting for over one month after
witnessing or experiencing a traumatic event (e.g. combat-related injury) are diagnosed
as PTSD.15 Estimates show 30%-60% of combat-injured veterans are diagnosed with
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PTSD, compared to an estimated 11%-20% in the general OIF/OEF veteran
population.16,17 Additionally, 50%-80% of OEF/OIF veterans diagnosed with PTSD also
report chronic pain.17 PTSD is believed to be a risk factor for transitioning from acute to
chronic pain.18 PTSD symptom severity may be a source of variability in how veterans
affected by chronic pain numerically rate their pain experience.19 Veterans with
significant PTSD symptomatology and chronic pain often experience increased pain
intensity, pain interference, and pain-related disability.20,21 Increased PTSD symptom
severity is believed to significantly amplify pain perception after injury, both in civilian22
and OEF/OIF23 veteran populations. Others have found trauma related pain is associated
with worse PTSD symptoms in veteran populations.25
The mutual presence of PTSD and chronic pain in OEF/OIF veterans has been
investigated since the onset of these conflicts.26-28 However, the relationship of pain and
PTSD in OEF/OIF combat-injured veterans is primarily examined using cross-sectional
or retrospective designs and PTSD is dichotomized as present or absent without
evaluating symptom severity or symptom trajectories.29,30 The few longitudinal
investigations of pain and PTSD symptom severity in OEF/OIF military personnel and
veterans are limited to one year follow up time periods, do not adjust for time since
injury, depend on self-reported injury status, and do not consider early pain
interventions.31-34 Trajectories of PTSD, or longitudinal changes in total symptom
severity, are generally characterized to be low-stable (resilient), worsening (chronic), or
improving over time (recovery/remitting), with numerous variations in these trajectories
based on time of observations and samples.35-38 The most prevalent PTSD symptom
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presentations seen in OEF/OIF military personnel and veterans is of the low-stable
symptom trajectory.35 Considering the significant impairment symptoms can have on
physical and social functioning, ongoing evaluation of PTSD symptoms in this
population is still warranted, even for individuals whose symptoms do not meet
diagnostic criteria. Changes in PTSD symptoms, even at early stages after combat injury,
have the potential to inform future care planning and monitoring for pain severity and
interference.
Early multimodal pain interventions following serious injuries can mitigate the lasting
effects of tissue trauma. Regional anesthesia (RA) has been shown to adequately provide
acute pain management for modern combat casualties in the austere environment40,41 and
throughout transportation,42 as well as safely deliver anesthesia and analgesia during the
preoperative, intraoperative, and postoperative periods.43 Use of RA is postulated to
reduce the risks of post-surgical complications after injury.42,50,55 Benefits of utilizing
RA, over systemic analgesics and anesthetics, include the avoidance of intubation for
mechanical ventilation, lower risk of hemorrhage, and more optimal postoperative
analgesia.49,55,56 Moreover, observational studies have suggested early pain management
after combat-injury, with either morphine44,45 or ketamine,46 has a protective effect on the
development of PTSD. These early pain interventions could potentially influence PTSD
trajectories, which in turn effect pain intensity and interference. RA, particularly as a
peripheral nerve block, can be an optimal mechanism for trauma patients with major limb
injuries due to the directed delivery of analgesics without systemic effects. Over half of
OEF/OIF combat-related injuries are extremity injuries47 and about 20% of these
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extremity injuries are serious and potentially fatal.48 The purpose of this secondary
analysis is to evaluate the association of RA and PTSD symptom trajectories with pain
intensity and interference in a sample of combat-injured OEF/OIF military personnel and
veterans.
Methods
Study Design
The Regional Anesthesia Military Battlefield Pain Outcomes Study (RAMBPOS) is a
prospective observational cohort study that investigated the effects of early aggressive
RA following major combat-related limb injuries sustained in the OEF/OIF conflicts by
United States (U.S.) military personnel and the subsequent patient-reported pain
outcomes. RAMBPOS enrollment began in October 2007 and data collection concluded
in September 2014. The research team at Corporal Michael J. Crescenz Veterans Affairs
(VA) Medical Center (Philadelphia, PA) collected participants’ patient-reported
outcomes via telephone. Attempts were made to collect patient-reported outcomes
monthly for individuals joining the study within the first 6 months after injury and every
3 months thereafter, for up to 24 months after combat injury. Individuals could join the
RAMBPOS study at any time after injury. Interviews with participants collected data on
pain intensity and interference, and mental health symptom severities, including PTSD.
Medical record review from The Department of Defense’s (DOD) Joint Theater Trauma
Registry, now known as the DOD Trauma Registry, provided clinical and military career
information, including date of injury, pain management and treatment status, and Injury
Severity Score (ISS). IRB approval for this secondary analysis was provided by the
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Department of Veterans Affairs (VA) Medical Center Research & Development
Committee and the University of Pennsylvania.
Participants
Participants were recruited from the former Walter Reed Army Medical Center
(Washington, DC), the current Walter Reed National Military Medical Center (Bethesda,
MD), and the U.S. Army Institute of Surgical Research at Brooke Army Medical Center
(San Antonio, TX). Participants with a combat-related major injury in one or more
extremities requiring hospitalization were eligible for enrollment in RAMBPOS.
Exclusion criteria included: moderate and severe traumatic brain injury (TBI), cognitive
deficits, inability to concentrate, poor judgment and impulse control, substantial hearing
loss, and bilateral upper extremity amputation with no alternate means to complete the
survey forms. Of the Six-hundred and eighty-seven (N = 687) combat-injured military
service members screened while inpatients or in rehabilitation, 301 did not meet
eligibility criteria for study enrollment. Three-hundred and eighty-six (N = 386)
participants consented, enrolled and provided data in RAMBPOS. Analysis was only
possible on participants with two or more patient-reported pain outcomes and PTSD
assessments, and 98 participants did not meet these criteria. The final sample for this
secondary analysis included 288 combat-injured military personnel with two or more
pain and mental health assessments within 24 months after injury. There was a mean of
7.47 observations per participant.
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Regional Anesthesia
Under ultrasound imaging an epidural or a peripheral nerve block, either intermittent or
continuous, is placed near a cluster of nerves through which RA is delivered to an area of
the body that requires localized pain management, such as a severely injured
extremity.53,54 RA, specifically peripheral nerve blocks, have been used to manage pain in
the austere environment, during transportation, preoperatively, and during acute care
following injuries in both Iraq and Afghanistan.3,41,42 Whether individuals received RA,
or not, was based on their proximity to a forward operating base, within a combat support
hospital, with a trained military anesthesia provider, and acute pain service deployed at
time of injury, as well as the availability of these services upon arrival in a U.S. military
hospital. RAMBPOS individuals who received RA within 14 days after injury were
compared to individuals who did not receive RA within 2 months after injury. RA receipt
was confirmed in the medical and surgical records upon enrollment. Participants not
receiving RA still received standard pain management including systemic multimodal
pain management throughout transportation and acute care at U.S. military medical
facilities. These consented and enrolled participants constitute the No RA cohort. RA was
the independent variable for this study.
Measures
Brief Pain Inventory
The Brief Pain Inventory (BPI) is a 9-item pain assessment tool measuring pain intensity
and pain interference.57 One of the strengths of the BPI is its ability to measure the
multiple dimensions of pain, including asking respondents to reflect on the extremes of
63

their pain experience, worst pain and least pain, to better contextualize the pain they are
reporting at time of assessment. Respondents rate their worst pain in the past 24 hours,
least pain in the last 24 hours, average pain, and pain right now (at time of assessment),
intensity on a scale of 0-10, with 0 being “no pain,” and 10 being “pain as bad as you
could imagine.” The interference section of the measure includes ratings for the degree to
which pain interferes with general activity, mood, walking, work, relationships, sleep,
and enjoyment of life from 0, “pain does not interfere”, to 10, “interferes completely”,
collectively known as pain interference.58,59 The BPI has been validated to accurately
assess for noncancer pain,60 chronic nonmalignant pain,61 and individuals experiencing
pain from orthopedic injuries.62 BPI pain intensity measures for worst, least, average, and
pain right now were each examined as primary outcomes. Pain interference was also a
primary outcome and scored as the mean of the seven interference items (i.e. general
activity, mood, walking, work, relationships, sleep, enjoyment of life).
Post-traumatic Stress Disorder Checklist
The Post-Traumatic Stress Disorder Checklist Military Version (PCL-M) is a 17-item
validated PTSD assessment instrument. Respondents rate the extent to which they have
experienced each of the 17 diagnostic symptoms for PTSD outlined in the Diagnostic and
Statistical Manual of Mental Disorders IV (DSM-IV), as related to stressful military
experiences.63-65 Total symptom severity scores are computed by adding the 17 items,
with each item scored based on the degree to which the symptoms bothered a participant
over the past month from “not at all” (1) to “extremely” (5). Total PCL-M scores range
from 17 to 85. The PCL-M can provide a presumptive diagnosis for PTSD.66 The VA
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National Center for PTSD recommends a minimum threshold of 30 for total symptom
severity score on the PCL-M be considered meeting PTSD diagnostic criteria.66
RAMBPOS participants completed the PCL-M as part of the battery of mental health
assessments provided by the Philadelphia VA Medical Center’s Behavioral Health Lab,
which is part of the VA’s measurement based mental health care initiative. PTSD was
examined as a covariate in this analysis.
Other Characteristics
The screening and baseline interviews assessed sociodemographic characteristics (e.g.
age, gender, race, ethnicity, education, marital status). Other covariates included the
length of hospitalization (in days), number of deployments, and Injury Severity Score
(ISS).
Injury Severity Score
The ISS is a scale used to evaluate anatomic injury severity following traumatic injury
that ranges from 0 to 75, with 75 indicating the greatest severity and incompatible with
life.67,68 The ISS is based on an Abbreviated Injury Scale (AIS) score allocated to the six
body regions (i.e. Head, Face, Chest, Abdomen, Extremities, and External). The highest
AIS score in each body region is used. The three most severely injured body regions
scores are squared and summed to produce the ISS. The ISS correlates linearly with
mortality, morbidity, hospital stay and other measures of severity. In this analysis ISS
was examined both linearly and categorically as Minor (£9), Moderate (10-15),
Moderate/Severe (16-24), and Severe/Critical (³25). The ISS is one of the most
consistently used numeric tools for quantifying trauma severity available in the DOD’s
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medical health records since the onset of either armed conflict.69 ISS was a covariate in
this analysis.
Statistical Analysis
Descriptive Statistics
Univariate descriptive statistics for both the RA and No RA cohort were calculated.
Bivariate statistical tests were conducted to assess if there were any statistically
significant differences between sociodemographic and injury variables, with and without
RA administration. Between group differences were compared with independent sample
t-tests or chi-square tests at baseline. Average PCL-M scores were compared between RA
cohorts.
PTSD Symptom Severity and Pain Intensity and Interference Correlations
The positive relationship between PTSD and pain intensity and interference was visually
inspected using bivariate scatter plots (Appendix Figures A3-1 to A3-5). Spearman’s
correlation estimates (rs) were calculated at each time point (i.e. month since injury to
observation), due to the non-normal distributions of PCL-M scores (Shapiro-Wilk = .834,
P < .001). This was done to assess the monotonic relationship between pain intensity and
interference, each separately, with PTSD symptom severity, using the PCL-M.
Correlation coefficients were categorized based on well-established guidelines.70
PTSD Symptom Trajectories
For this analysis, PTSD symptom severity was examined based on PCL-M total symptom
severity scores. Models included participants’ first PCL-M scores in the study, referred to
as an initial PTSD presentation. The primary interest was the change over time in pain
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and PTSD. However, baseline values included in the modeling controlled for
intraindividual variability. Next, PTSD symptom trajectories were calculated as the
overall difference in an individual’s first PCL-M score and an individual’s last observed
PCL-M score, over the time difference:
!"#$ &'()* =
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PTSD symptom trajectories were characterized (Figure 3-1) from a continuous
variable into an indicator term: (1) individuals with a worsening trajectory (e.g. PTSD
symptoms increase over time), (2) individuals with stable trajectories (e.g. PTSD
symptoms do not get better or worse), and (3) individuals with an improving trajectory
(e.g. PTSD symptoms decrease over time). This was done to maximize the number of
participants in the improving and worsening trajectories to better assess the effects of
either trajectory. Sensitivity analyses were conducted with a wider caliber for the stable
trajectory (See Appendix Table A3-2). Distribution of PTSD symptom trajectory
categories were examined across each RA cohort. Of note, unadjusted least squares linear
regression slopes were fitted and found to be of poorer fit than using the two-point
derived slopes to estimate pain outcomes (Likelihood-ratio test, c2= 35.96, P < 0.001).
Time
Time was defined as the number of months since injury that a pain outcome measure was
observed (i.e. months 0 to 24). When used as a continuous random-effect in the model,
time accounts for both within and between subject variability in point estimates. All
individuals in this analysis had at least two-time points separated by at least one or more
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months. Therefore, a random intercept unique to each individual was used in the model
parameter estimates. An indicator variable for time since injury and time to first
observation in the study, known as the study entry cohort, was included in the model to
account for potential selection bias. The study entry cohorts were categorized as less than
6 months, between 6-12 months, or over 12 months since injury. The majority of
participants, 76.74%, entered the study within 6 months of injury, 15.97% entered
between 6 months to a year after injury, and 7.69% of participants entered over a year
after injury.
Mixed Effect Models
Linear mixed effects models examined whether longitudinal progression of the outcomes,
pain intensity and pain interference, are associated with an individual receiving RA and
PTSD symptom trajectories. Linear mixed effects models are extensions of simple linear
models, such as linear regression, and incorporate both fixed and random effects.71,72 This
approach accounts for collinearity between individuals’ repeated outcome measures.
First, bivariate models were fit to assess the association of each fixed effect (e.g. RA
receipt status, ISS, length of hospitalization) to pain outcomes. A forward stepwise
variable selection process was utilized. Goodness of fit for each model was assessed
using Akaike information criterion (AIC).73 Each model includes a random intercept and
slope to account for individual differences in the time between injury to observation (i.e.
the number of months after injury that the outcome measure was recorded per person).
Both a model with random intercept only, and a model with random slope only were
assessed for goodness of fit and compared to the combined random intercept and slope
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model. The combined intercept and slope model was determined to be best fitting based
on AIC to account for time since injury and time of observation per person.
Mixed effects models were constructed to evaluate the association of initial PTSD
clinical presentations on estimating pain intensity and interference, separately. Both the
initial PTSD clinical presentations and the symptom trajectories are treated as fixedeffects in the models. Sensitivity analyses included generating models after controlling
for baseline pain intensity and interference. Interaction terms between treatment (RA) and
time (month since injury) were not significant and did not increase model fits compared
to those models without interaction terms, based on AIC. Initial BPI measures, or an
individual’s baseline, were used in sensitivity analyses. Given the difference in the
spacing of measurements and AIC values, an identity covariance matrix was used to
account for the model residuals. Model parameters were estimated using maximum
likelihood with degrees of freedom derived using the Satterthwaite method, after
comparing against full restricted maximum likelihood estimation (REML) for
parameters.74,75 A P-value less than .05 was considered significant. All analyses were
conducted with Stata® 15.0 (Stata Corp SP, College Road, TX, USA).
Results
Descriptive Statistics and Baseline Associations
The sample, at baseline, was predominately young (28.10 years old, +/- 7.00), White
(76.39%), and almost exclusively male (98.96%) (Table 3-1). In this sample, 149
participants received RA and 139 participants did not receive RA within two weeks of
injury. The cohorts were statistically equivalent on most sociodemographic and injury
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characteristics, except for marital status (P = .032) where the RA cohort had a higher
percentage who were married (55.70% compared to 41.01%), and an average length of
hospitalization (P < .001) about 14 days longer (44.10 days compared to 29.90 days).
There was no significant difference in the proportion of individuals meeting diagnostic
levels of PTSD at time of entry into the study. Mean PCL-M total symptom severity
score at baseline was not statistically different between the RA cohorts and the proportion
of individuals with slope changes worsening, improving, or stable was not significantly
different between cohorts. The average PCL-M score among individuals with worsening
PTSD symptom trajectories (30.60 +/- 13.44) was highest compared to those with an
improving PTSD (26.80 +/- 11.40) symptom trajectory and those with a stable trajectory
(21.00 +/- 8.61). The time to entry in study and symptom trajectory interaction term was
not significant, indicating there was no effect of entry on PTSD symptom severity.
Longitudinal Associations with Pain Intensity, Interference, and PTSD
Worst pain and PCL-M score correlation coefficients indicated a moderate positive
monotonic relationship (rs ≥.51) at several time points within, and at the first 12 months
after injury (i.e. months 6, 10, 12) and beyond up to 14 months after injury. The
correlations at these time points were significant (P < .02). A moderate positive
correlation coefficient between least pain and PCL-M was seen at 6 months (P = .007)
and again at 13 months (P = .001). There was a high positive correlation (rs ≥.71)
between, average pain and PCL-M at 6, 13, 16 months that is statistically significant (P <
.010. Pain right now and PCL-M were statistically significantly associated, with high
positive monotonic relationship seen at 6, 13, and 16 months after injury (P < .01). This
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strong association, high positive correlation, was seen between pain interference and
PCL-M scores exclusively after one year of injury, at months 16, 17, and 18 months (P <
.05). However, moderate positive correlation coefficients were seen between pain
interference and PCL-M that were statistically significant across the first two years after
injury and up to twenty-one months. A statistically significant low to moderate positive
correlation is seen up to twenty-one months after injury for all pain intensity and
interference measures, except least pain. These findings are illustrated in Table 3-2. A
low negative correlation, between all pain outcomes and PCL-M scores, was observed at
under one month after injury, however this association was not statistically significant.
Initial Presentations of Pain and PTSD Mixed Effects Models
A set of models was constructed to evaluate how an individual’s initial PTSD
presentation was associated with pain intensity and interference, over time in the study
(Table 3-3). The treatment effect of RA on mean worst pain, least pain, average pain, and
pain right now was statistically significant, indicating better pain management compared
to those without RA (β = -.393, P =.001; β = -.263, P < .001; β = -.373, P < .001; β = .0274, P = .006, respectively). The treatment effect was not significant for pain
interference. The time by treatment interaction was not significant and not included in the
final analysis. Estimates for worst pain, average pain, pain right now, and pain
interference decrease, with statistical significance, with each month after injury (β = .031, P = .001; β = -.028, P < .001; β = -.019, P = .013; β = -.040, P < .001, respectively).
Length of hospitalization remained statistically significant in estimating worst pain (β =
.006, P = .007), average pain (β = .003, P = .037), and pain interference (β = .006, P =
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.001), with increased length of stays associated with increased patient-reported pain
outcome estimates, adjusting for all other variables. However, given the small parameter
estimates, this effect is not clinically meaningful. ISS was not statistically significant in
the estimates of the association with any pain intensity and interference outcome.
However, ISS and length of hospitalization were moderately positively correlated
(Appendix Figure A3-1). Married participants experienced statistically significantly
higher pain scores for worst pain, pain right now, and pain interference (β = .364, P =
.001; β = .211, P = .032; β = .499, P < .001, respectively), when compared to the single
participants. Being a divorced or separated participant was associated with the highest
pain interference scores, compared to single participants (β = .650, P = .001). Time to
entry in the study was significant in estimating the association with pain intensity and
interference. Individuals entering the study after one year of injury were estimated to
have statistically significantly higher worst pain, least pain, average pain, and pain right
now (β = 1.010, P = .003; β = .476, P = .020; β = .674, P = .008; β = .629, P = .048,
respectively).
Initial PCL-M scores were statistically significant (P < .001) in the model estimating
the association with all pain outcomes. More symptomatic individuals, or those with
elevated PCL-M total symptom severity scores, were estimated to have higher BPI pain
intensity (i.e. worst, least, average, and pain right now) and interference scores. PCL-M
scores remained statistically significant even after adjusting for initial pain presentations
in the model. For example, including mean initial average pain scores in the model was
found to have a statistically significant effect on estimating future average pain, on the
72

BPI (β = .545, P < .001). This indicates that elevated pain intensity and interference upon
entry into the study, across all BPI measures, are associated with higher estimated pain
outcomes in the future (P < .001).
PTSD Symptom Trajectory Mixed Effects Models
Individuals receiving RA experienced less intense worst pain, least pain, average pain
and pain right now scores than the comparative non-RA cohort at any time point (β = .353, P = .002; β = -.253, P < .001; β = -.343, P < .001; β = -.274, P = .006, respectively)
(Table 3-4). Figures 3-2 to 3-6 illustrate this association between RA receipt and pain
outcomes. RA was not statistically significantly associated with pain interference. The
time by treatment interaction term was not significant and was not included in the
analysis. Time since injury, measured in months, remained statistically significant in
models for worst pain, average pain, pain right now, and pain interference, indicating that
over the course of the study, patient-reported pain intensity and inference decreased (β = .030, P < .001; β = -.027, P < .001; β = -.017, P = .031; β = -.037, P < .001, respectively).
Time since injury was not statistically significant in estimating least pain. Alternatively,
longer length of hospitalization after initial injury, measured in days, led to small
incremental, and statistically significant, increases in patient-reported pain outcome
scores (worst pain, β = .006, P = .010; least pain, β = .002, P = .047; average pain, β =
.003, P = .037; pain interference, β = .005, P = .002). ISS was not statistically significant
in any model estimating pain outcomes, indicating that there is no statistical difference in
pain intensity and interference estimates by injury severity.
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Other covariates were found to be associated with pain intensity and interference.
This includes a participant’s marital status. Being married, or having a partner, was
associated with participants reporting higher worst pain (β = .331; P = .004), pain right
now (β = .201; P = .046), and pain interference (β = .456; P < .001), compared to single
participants. Divorce or separated participants experienced the highest pain interference
compared to single participants (β = .766; P < .001) Late entry to the study (i.e. more
than 1 year after injury) was again associated with experiencing higher worst pain
intensity, but not pain interference (worst pain, β = 1.067; P = .002; least pain, β = .566;
P = .006; average pain, β = .741; P = .004; pain right now, β = .740). First pain measures
were associated with the largest coefficients of pain outcomes (worst pain, β = .607; P <
.001; least pain, β = .577; P < .001; average pain, β = .581; P < .001; pain right now, β =
.588; P < .001; pain interference, β = .578; P < .001).
There was a statistically significant difference in the worst pain, average pain, pain
right now, and pain interference estimates based on PTSD symptom trajectories (Table
3-4). Worsening PTSD symptoms were associated with higher pain intensity. When
compared to those with improving PTSD symptom trajectories, individuals with
worsening PTSD symptom trajectories experienced higher average pain (β = .203, P =
.018), and pain right now (β = .373, P < .001), controlling for all other covariates and
accounting for RA status. However, individuals with stable PTSD symptom trajectories
were estimated to have a statistically significant decrease in their worst pain (β = -.384, P
= .049), and pain interference (β = -.511, P = .001) compared to those with improving
PTSD symptom trajectories. PTSD symptom trajectories were not associated with least
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pain outcomes. This differential pain response by PTSD symptom trajectory is most
evident when graphing the marginal linear estimates (Figures 3-7 to 3-11).
Discussion
The findings from this analysis identified that initial PTSD symptom severity and PTSD
symptoms trajectories were associated with statistically significant changes in pain
intensity and interference. Additionally, combat-injured military personnel and veterans
receiving RA had lower patient-reported pain outcomes than individuals not receiving
RA. RA is an effective pain management intervention for controlling pain following
combat-related injuries.41,50,51,76,77 Findings demonstrate the potential long-term benefits
of early RA in a combat-injured cohort, seen months after initial RA treatment. This is
evident by a decrease in all pain intensity measures over time compared to individuals not
receiving early aggressive multimodal RA. Other investigations have found RA to
improve the pain experience after combat injury, however, these studies are often limited
to showing the short-term advantages of RA.3,42,78,79 Often study periods fall short of
capturing the lasting benefits of early aggressive pain management with RA, as
accomplished in this study. Other cross-sectional studies of combat-injured service
members, and prospective studies of shorter duration, clearly support that RA is
responsible for improvements in pain outcomes.4,51,78 The prospective longitudinal
investigation of RAMBPOS enables the simultaneous evaluation of the association of
PTSD symptoms and pain, unlike other investigations of early acute pain management
which are cross-sectional or retrospective in nature. The ability to observe differences in
pain intensity and interference, and PTSD symptom trajectories in a longitudinal manner
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is critically important to justify the sustained value of early RA.
There is a low to moderate positive correlation between worst pain and PTSD, least
pain and PTSD, and average pain and PTSD total symptom severity up to twenty-one
months after injury. Pain interference and PTSD total symptom severity are positively
correlated at multiple times within one year after injury. However, the strongest
association between conditions are seen beyond one year after injury. Correlation
coefficients are similar to shorter year-long investigations of PTSD and pain among
veterans, which also found symptoms to be significantly moderately correlated.25,33
In this study, the initial PCL-M score was significantly associated with pain intensity
and interference. This supports other’s findings that PTSD symptoms are found to be
significantly associated with higher patient-reported pain after injury.32,33 There is a wellestablished relationship between the mutual presentations of PTSD and pain after
experiencing a combat-related injury.80-82 However, this study differs from previous
studies examining the presence of these mutual conditions with single items, and instead
utilizes a validated multi-item patient-reported pain scale, the BPI.25 In RAMBPOS,
participants with stable PTSD symptom trajectories had the lowest pain intensity,
followed by those with improving PTSD symptom trajectories, and finally individuals
with worsening PTSD symptom trajectories experienced the highest pain intensity,
specifically average pain and pain right now. Both Stratton et al. and Jenewein et al.,
identified that PTSD symptom severity significantly impacted pain intensity in
participants up to a year after enrollment in their respective studies, but pain did not exert
the same strength on predicting PTSD.33,83 Vaughan et al. and Bartoszek et al. have
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demonstrated that pain intensity influences exasperations of specific PTSD
symptoms.25,32 Conversely, considering Alschuler et al. found that PTSD symptom
severity may cause variability in pain outcomes, further evaluation of the effects of PTSD
on pain intensity and interference is warranted.19,84 Additionally, other longitudinal
investigations between PTSD symptoms and pain are often limited to one year and are
not specific to OEF/OIF combat-injured American military personnel and
veterans.25,32,33,83 The average PCL-M scores per PTSD symptom trajectory group in this
analysis (e.g. stable, worsening, improving), are slightly lower those seen in larger
cohorts reported by both Bonanno et al.’s and Berntsen et al.’s studies of non-combat
injured OEF/OIF personnel.38,85
This secondary analysis investigated the influence of selected covariates in the mixed
effects model on pain, after receiving RA. Worsening PTSD symptom trajectories,
marital status, month of observation, prolonged length of hospitalization, entering the
study more than a year after injury, and initial pain intensity were associated with poorer
pain outcomes. Consistent with previous findings in the injury literature, pain intensity
and interference decrease with time.33 Initial pain intensity and interference were
significant indicators of future pain outcomes, which is comparable to other investigators’
findings that initial pain intensity predicts pain up to six and twelve months later.33,86
Anatomic injury severity was not significant in predicting longitudinal pain intensity or
interference in the RAMBPOS population, which is consistent with some civilian
research. 83 However, other authors have questioned the utility of the ISS in accurately
capturing the severity of penetrating injuries and military combat-related trauma and the
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need for physiologic indicators of injury severity.87 The moderate positive correlation
between ISS and length of hospitalization could potentially reduce the effect of ISS in the
final model, despite fitting the data most appropriately. Other factors in our study
included that married individuals, compared to single combat-injured military personnel
and veterans, experienced poorer pain intensity. Divorced and separated participants had
higher pain interference than single participants. Length of hospitalization after injury
was significant in estimating pain outcomes, and while consistent with other’s findings,
the effect has little clinical value.88 The small number of individuals entering the study a
year after injury reported higher pain intensity and interference, compared to those
enrolled closer to time of injury. While this could introduce sample bias, this small
number of participants was evenly distributed between RA and No RA cohorts. There
was no difference between cohorts by age, sex, race, education, or number of
deployments and were not included in the final analysis. This sample consisted of mostly
white males and therefore insufficiently powered to detect pain outcomes across racial
status or sex. A large proportion of participants in the parent study had less than two
PCL-M observations and were therefore not included in this analysis. The PCL-M was a
secondary outcome in RAMBPOS that was less frequently collected compared to the BPI
Advancing current understanding of symptom trajectories will allow scientists and
clinicians to better plan for the long-term health care requirements of populations with
serious injuries. Patients, families, and health providers recognize the health needs of
individuals with serious injuries continue long after acute care.89 Introduced more than
two decades ago, multimodal analgesia is currently recommended for treating both acute
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and chronic pain.40 The synergy created when multimodal regimens are used to target
discrete components of the peripheral and central pain pathways provides effective
analgesia at lower opioid dosing, reducing related risk and producing fewer adverse
effects.90 Advanced training of anesthesiologists and certified registered nurse
anesthetists in RA is critical to ensuring that optimal pain management approaches are
available to improved recovery of all injured persons.91 Importantly, advanced pain
providers do not exist in silos, and combat-injured veterans depend on the support of
interdisciplinary care providers, including mental health providers.80,92 Given the
significant role PTSD symptom trajectories were found to have in this analysis, clinicians
noticing changes in symptom trajectories of PTSD in military personnel and veterans
during their prolonged rehabilitative care should consider the implications these changes
have on pain outcomes. Due to the co-occurring nature of these conditions, and the
potential for individuals to underreport PTSD symptom severity, integrated pain and
mental health symptom assessments are key to connecting patients to treatment for
underlying psychological contributions of pain. Systematic observation of symptom
severities requires that individuals with combat injuries be assessed using standardized
mental health and pain screenings, including population specific tools such as Pain
Assessment Screening Tool and Outcomes Registry (PASTOR®) and the Defense and
Veterans Pain Rating Scale (DVPRS).93,94
It is important to consider limitations of this research, many of which are common
with longitudinal observational studies and investigations with recently injured military
and veteran populations. Given the challenges of recruiting and retaining a sample of
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combat-injured participants, there was a high degree of variability as to when participants
entered the study and how long they remained in the study. For recruitment, every effort
was made to enroll participants at the time of discharge from acute care at only two
military hospitals in the US. Extended follow-up of these patients was further
complicated by the dispersion of subject across the U.S. following discharge. This
created considerable challenges in finding and following subjects, and thus, patientreported outcome data was available for an average of about 7.5 time points for each
patient, ranging from 2 to 12 observations, and not available on all patients at all time
points (Appendix Table A3-1). It is hypothesized that the lack of participation was
predominately driven by the challenges of re-integration and large movement of soldiers
upon returning to the U.S. One might expect people with fewer problems to be less likely
to respond so our sample may be biased towards those with more difficult problems. This
would tend to push results towards the null, and considering there was a difference at all,
supporting RA was effective on improving pain outcomes, is an indication that the
difference is more likely to represent the true effect of the treatment. Unlike other
methods used to assess the relationship between PTSD symptom severity and pain,
modeling approaches in this analysis are not as sensitive to data missing at random and
can adjust for disparate data points in the analysis. Mixed effects models utilize all
available data, while simultaneously adjusting for correlation between an individual’s
repeated observations even when observations are unequally spaced.72 This modeling
approach estimates average time trends for entire treatment groups, or in this case RA vs
No RA, and individual’s responses over time, even when data are missing at random.
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Additionally the almost exclusively male sample limits the generalizability of findings to
female combat-injured military personnel.
Even with these limitations, the RAMBPOS is one of the most comprehensive
repeated measures datasets of multivariable patient-reported pain and pain-related
outcomes to examine the effects of early RA after injury. An individual’s likelihood of
receiving RA was not randomized given the ethical considerations, but rather based on
the time of deployment and proximity to a trained RA provider at time of injury in the
austere combat environment and throughout acute care in a U.S. military healthcare
facility. Patients with similar injuries may or may not have received RA based on factors
independent from the study, which should reduce potential selection biases between the
RA cohorts. PTSD symptom manifestation can take several weeks to months to present
clinically and therefore the linearity imposed on the PTSD trajectories may not accurately
capture variability in presentations. Further, this analysis examined total PCL-M total
symptom severity scores and did not consider the effects of specific PTSD symptoms on
pain outcomes. RAMBPOS participants’ PTSD total symptom severity was measured
using the DSM-IV criteria, which has been found to identify similar prevalence rates of
PTSD as the more recent DSM-5 criteria in OEF/OIF veteran populations.95 All
individuals in the sample experienced a mild TBI (mTBI), due to their proximity to
improvised explosive devices and subsequent blast exposure. Moderate and severe TBI
have been found to influence pain,96 but mTBI alone has not been found to be associated
with increased pain. While this study examined the effects of PTSD symptom trajectories
on pain outcomes, it has been proposed this relationship is bidirectional with the negative
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impact of PTSD symptoms on chronic pain, and vice versa.8 Strengths of the current
study include the ability to account for time since traumatic combat injury to observation
in order to provide longitudinal estimates of outcomes, and the adjustment for initial
acute pain management interventions considering the influence this may have on PTSD
and pain.
Conclusion
RA is an effective acute pain management intervention when used as part of an
interdisciplinary approach to comprehensive trauma care. RA is associated with longterm benefits in reducing pain intensity after combat injury. PTSD, pain intensity, and
interference are correlated in the initial months after injury and up to twenty-one months
after, which suggests that better pain control may help reduce PTSD. There are also
differential responses in pain intensity and interference based on PTSD symptom
trajectories. Individuals with worsening PTSD symptom trajectories are estimated to
experience higher average pain and pain right now following combat injury compared to
individuals with improving PTSD trajectories. Findings underscore the need for early
aggressive pain therapy including RA after serious injury. Continued evaluation of both
pain-related outcomes and PTSD symptoms, have the potential to inform the
development and implementation of comprehensive rehabilitative services after injury.
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Table 3-1: Sample Characteristics
Total
N=288
Agea
Mean
28.10
Std. dev.
7.00
Sexb
Female
1.04%
Male
98.96%
Raceb
White
76.39%
Black
4.51%
Other
19.10%
Ethnicityb
Hispanic
12.85%
Not Hispanic
87.15%
Educationb
HS Grad/GED
42.36%
Some College
39.58%
College Grad
18.06%
Marital Statusb
Single
45.49%
Married/Partnered
48.61%
Separated/Divorced
5.90%
Number of Deploymentsa
Mean
2.00
Std. dev.
1.09
Length of Stay in
Hospitala
Mean
34.55
Std. dev.
30.30
Injury Severity Scorea
Mean
17.77
Std. dev.
10.13
ISS Categoryb
21.18%
Minor (£9)
Moderate (10-15)
24.65%
Serious (16-24)
34.03%
20.14%
Severe (³25)
PTSD Diagnosis when
Entering Studyb
No
36.37%
Yes
12.24%
PCL-M Scorea
Mean
29.59
Std. dev.
14.30
PCL-M Symptom
Trajectoryb

No RA
n=139

RA
n=149

28.30
7.90

28.00
6.10

Test
Value

PValue

0.39

0.698

1.44%
98.56%

2
137

0.67%
99.33%

1
148

0.41

0.521

74.82%
7.19%
17.99%

104
10
25

77.85%
2.01%
20.13%

116
3
30

4.54

0.103

10.79%
89.21%

15
124

14.77%
85.23%

22
127

1.01

0.314

44.60%
43.17%
12.23%

62
60
17

40.27%
36.24%
23.49%

60
54
35

5.49

0.064

51.08%
41.01%
7.91%

71
57
11

40.27%
55.70%
4.03%

60
83
6

6.88

0.032

1.90
1.10

2.02
1.09

0.38

0.809

29.90
33.10

44.10
32.30

-3.70

<.001

17.72
10.88

17.83
9.43

-0.09

0.930

24.46%
23.02%
30.94%
21.58%

34
32
43
30

18.12%
26.17%
36.91%
18.79%

27
39
55
28

2.69

0.442

104
35

74.50%
25.50%

111
38

0.83

0.361

-0.37

0.711

n
74.82%
25.18%
29.00
14.00

30.12
14.80
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Table 3-1: Sample Characteristics
Total
N=288
Improves
49.90%
Stable
13.40%
Worsens
36.70%
Observations Per
Participant
Mean
7.47
Std. dev.
2.57
Time Since Injury to
Entering Studyb
≤ 6 Months
76.74%
6 Months ≤ 1 Year
15.97%
> 1 Year
7.29%
PTSD Improving
(PCL-M Score)a
Mean
26.80
Std. dev.
11.40
PTSD Stable
(PCL-M Score)a
Mean
21.00
Std. dev.
8.61
PTSD Worsening
(PCL-M Score)a
Mean
30.60
Std. dev.
13.44
Worst Pain
(BPI Score) a
Mean
4.86
Std. dev.
2.53
Least Pain
(BPI Score)a
Mean
1.13
Std. dev.
1.44
Average Pain
(BPI Score)a
Mean
2.42
Std. dev.
2.20
Pain Right Now
(BPI Score)a
Mean
1.93
Std. dev.
1.80
Pain Interference
(BPI Score)a
Mean
1.81
Std. dev.
1.57
a

No RA
n=139
46.60%
57
11.90%
13
41.50%
69

7.50
2.44

80.58%
13.67%
5.76%

RA
n=149
0.50
0.12
0.38

62
16
71

7.44
2.71

112
19
8

73.15%
18.12%
8.72%

109
27
13

Test
Value

PValue

0.20

0.905

0.53

0.592

2.28

0.320

26.74
11.61

26.80
11.25

-0.05

0.961

21.06
9.48

20.98
7.87

0.05

0.962

30.69
13.27

30.52
13.62

0.11

0.914

5.03
2.67

4.71
2.41

1.06

0.290

1.10
1.40

1.14
1.48

-0.28

0.783

2.57
1.86

2.27
1.92

1.35

0.179

1.92
1.97

1.93
1.80

0.04

0.966

1.89
2.32

1.74
1.94

0.59

0.555

b

t-test chi-square Coeff.=coefficient; Std. dev=standard deviations; BPI=Brief Pain Inventory; ISS= Injury Severity Score
PCL=PTSD Checklist
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Table 3-2: Pain Intensity and PTSD Spearman’s Rank Correlation Coefficients (rs) , by Month Since Injury (N=288)
Little if any correlation
.00 to .30 (.00 to -.30)

Low positive (negative) correlation
.31 to.50 (-.31 to -.50)

Worst Pain
Month
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

Obs.

rs

8
66
57
30
22
19
17
27
107
24
13
7
20
22
90
26
10
10
14
22
71
27
9
4
14

-0.43
0.37
0.12
0.40
0.30
0.26
0.54
0.30
0.32
0.40
0.64
0.70
0.66
0.45
0.52
0.20
0.48
0.58
0.53
0.34
0.32
0.44
-0.17
0.32
0.49

Moderate positive (negative) correlation
.51 to .70 (-.51 to -.70)

Least Pain
P
Value
0.288
0.002
0.383
0.027
0.181
0.291
0.026
0.135
<0.001
0.050
0.019
0.062
0.002
0.034
<0.001
0.323
0.159
0.076
0.529
0.119
0.007
0.021
0.654
0.684
0.076

Obs.

rs

10
77
63
36
28
20
20
34
127
27
14
10
25
30
104
30
10
10
15
26
80
33
12
7
14

-0.16
0.33
0.11
0.22
0.33
-0.03
0.58
0.37
0.21
0.46
0.01
0.39
0.43
0.58
0.45
0.45
0.60
0.33
0.39
0.25
0.40
0.34
0.37
0.14
0.12

Average
P
Value
0.655
0.003
0.374
0.193
0.082
0.885
0.007
0.030
0.016
0.017
0.386
0.270
0.033
0.001
<0.001
0.013
0.679
0.359
0.156
0.224
<0.001
0.051
0.242
0.757
0.688

Obs.

rs

10
77
63
36
28
20
20
34
127
27
14
10
25
30
104
30
10
10
15
26
80
33
12
7
14

-0.13
0.40
0.19
0.43
0.43
0.02
0.71
0.53
0.38
0.49
0.58
0.35
0.42
0.73
0.48
0.48
0.79
0.60
0.55
0.49
0.39
0.57
0.50
0.16
0.50
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High positive (negative) correlation
.71 to 1.00 ≤ (-.71 to -1.00)

Pain Right Now
P
Value
0.719
<0.001
0.127
0.009
0.023
0.949
<0.001
0.001
<0.001
0.009
0.029
0.324
0.035
<0.001
<.0001
0.008
0.006
0.066
0.035
0.011
<0.001
<0.001
0.099
0.739
0.854

Obs.

rs

10
77
63
36
28
20
20
34
127
27
14
10
25
30
104
30
10
10
15
26
80
33
12
7
14

-0.33
0.32
0.21
0.26
0.55
0.09
0.74
0.41
0.29
0.37
0.27
0.19
0.46
0.71
0.47
0.40
0.75
0.54
0.69
0.42
0.47
0.51
0.33
0.31
0.33

P
Value
0.351
0.004
0.1
0.1
0.003
0.694
<0.001
0.015
<0.001
0.055
0.347
0.593
0.022
<0.001
<0.001
0.028
0.013
0.108
0.004
0.033
<0.001
0.003
0.288
0.499
0.232

Pain Interference
Obs.

rs

10
76
59
34
24
19
18
28
111
25
14
7
21
24
92
28
10
10
14
22
73
29
10
4
14

-0.01
0.43
0.43
0.53
0.63
0.23
0.67
0.41
0.47
0.57
0.62
0.51
0.60
0.60
0.55
0.66
0.86
0.75
0.76
0.62
0.60
0.63
0.03
0.60
0.40

P
Value
0.987
<0.001
<0.001
0.001
0.001
0.347
0.002
0.033
<0.001
0.003
0.019
0.243
0.001
0.002
<0.001
0.001
0.001
0.013
0.001
0.002
<0.001
<0.001
0.981
0.400
0.156

Table 3-3: Initial Presentations of Pain and PTSD (N=288)

Intercept
Regional Anesthesia
No
Yes
Month Since Injury (0-24)
Initial PTSD Checklist Score (17-85)
Injury Severity Score
Minor [Reference]
Moderate
Serious
Severe
Length of Hospitalization (Days)
Marital Status
Single [Reference]
Married/Partnered
Separated/Divorced
Entry Cohort
≤ 6 Months [Reference]
6 Months ≤ 1 Year
> 1 Year
First Pain Measure

Coef.

Worst Pain
LCI
UCI

1.721

1.317

-0.393
-0.031
0.020

Least Pain
LCI
UCI

P - Value

Coef.

P - Value

2.125

< .001

0.039

-0.180

0.258

0.728

-0.621
-0.048
0.011

-0.165
-0.015
0.030

0.001
< .001
< .001

-0.263
0.001
0.016

-0.396
-0.008
0.010

-0.129
0.011
0.022

< .001
0.781
< .001

-0.060
-0.060
0.071
0.006

-0.363
-0.365
-0.287
0.002

0.244
0.246
0.429
0.010

0.700
0.702
0.698
0.007

0.130
-0.013
0.041
0.002

-0.048
-0.191
-0.168
0.000

0.308
0.166
0.249
0.005

0.153
0.891
0.701
0.059

0.364
0.249

0.140
-0.218

0.588
0.717

0.001
0.296

0.059
-0.183

-0.072
-0.455

0.189
0.090

0.378
0.189

-0.129
1.010
0.577

-0.526
0.335
0.530

0.268
1.685
0.624

0.524
0.003
< .001

-0.039
0.476
0.538

-0.273
0.075
0.492

0.195
0.876
0.585

0.745
0.020
< .001

Coeff = coefficient; UCI = upper 95% confidence interval; LCI = lower 95% confidence interval; RA = regional anesthesia; BPI = brief pain inventory; PTSD = post-traumatic stress disorder; Initial
pain presentation score= the same, initial BPI score corresponding to the outcome measure
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Table 3-3 (continued)
Average Pain

Pain Right Now

Pain Interference

Coef.

LCI

UCI

PValue

Coef.

LCI

UCI

PValue

Coef.

LCI

UCI

PValue

0.864

0.584

1.144

< .001

0.129

-0.187

0.445

0.425

-0.160

-0.461

0.141

0.298

No

-

-

-

-

-

-

-

-

-

-

-

-

Yes

-0.373

-0.541

-0.205

< .001

-0.274

-0.468

-0.080

0.006

-0.056

-0.237

0.126

0.549

-0.028

-0.040

-0.016

< .001

-0.019

-0.034

-0.004

0.013

-0.040

-0.053

-0.027

< .001

0.020

0.013

0.027

< .001

0.027

0.019

0.035

< .001

0.039

0.031

0.047

< .001

-

-

-

-

-

-

-

-

-

-

-

-

Moderate

-0.079

-0.302

0.145

0.491

-0.168

-0.425

0.089

0.199

0.133

-0.109

0.375

0.281

Serious

-0.059

-0.284

0.166

0.608

-0.037

-0.295

0.221

0.778

-0.049

-0.292

0.194

0.693

Severe

-0.066

-0.328

0.197

0.624

-0.219

-0.522

0.084

0.157

0.076

-0.209

0.360

0.601

0.003

0.000

0.006

0.037

0.003

-0.001

0.006

0.140

0.006

0.002

0.009

0.001

Single [Reference]

-

-

-

-

-

-

-

-

-

-

-

-

Married/Partnered

0.158

-0.009

0.324

0.064

0.211

0.019

0.404

0.032

0.499

0.321

0.677

< .001

Separated/Divorced

0.060

-0.283

0.403

0.731

-0.039

-0.433

0.356

0.847

0.650

0.279

1.022

0.001

-

-

-

-

-

-

-

-

-

-

-

-

6 Months ≤ 1 Year

0.143

-0.151

0.436

0.340

0.252

-0.111

0.616

0.174

0.025

-0.289

0.338

0.877

> 1 Year

0.674

0.176

1.172

0.008

0.629

0.005

1.253

0.048

0.518

-0.015

1.050

0.057

0.545

0.498

0.593

< .001

0.556

0.509

0.603

< .001

0.485

0.443

0.527

< .001

Intercept
Regional Anesthesia

Month Since Injury (0-24)
Initial PTSD Checklist Score (1785)
Injury Severity Score
Minor [Reference]

Length of Hospitalization (Days)
Marital Status

Entry Cohort
≤ 6 Months [Reference]

First Pain Measure

Coeff = coefficient; UCI = upper confidence interval; LCI = lower confidence interval; RA = regional anesthesia; BPI = brief pain inventory; PTSD = post-traumatic stress disorder; Initial pain
presentation score= the same, initial BPI score corresponding to the outcome measure
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Table 3-4: Mixed Effects Model with PTSD Trajectory (N=288)
Worst Pain
Intercept
Regional Anesthesia
No [Reference]
Yes
Month Since Injury (0-24)
Change in PTSD Slope
Improving (¯) [Reference]
Stable («)
Worsening ()
Injury Severity
Minor [Reference]
Moderate
Serious
Severe
Length of Hospitalization
(Days)
Marital Status
Single [Reference]
Married/Partnered
Separated/Divorced
Entry Cohort
≤ 6 Months [Reference]
6 Months ≤ 1 Year
> 1 Year
First Pain Measure

Least Pain

Coef.

LCI

UCI

P - Value

Coef.

LCI

UCI

P - Value

2.172

1.797

2.548

< .001

0.344

0.152

0.535

< .001

-0.353
-0.030

-0.582
-0.047

-0.125
-0.014

0.002
< .001

-0.253
0.002

-0.387
-0.008

-0.119
0.012

< .001
0.663

-0.384
-0.039

-0.767
-0.273

-0.002
0.195

0.049
0.746

0.039
0.113

-0.187
-0.022

0.264
0.247

0.736
0.100

-0.034
-0.042
0.032

-0.338
-0.348
-0.328

0.270
0.263
0.392

0.825
0.786
0.860

0.162
-0.004
0.005

-0.017
-0.183
-0.205

0.341
0.176
0.216

0.077
0.968
0.961

0.006

0.001

0.010

0.010

0.002

0.000

0.005

0.047

0.331
0.321

0.104
-0.148

0.559
0.790

0.004
0.180

0.059
-0.145

-0.075
-0.420

0.192
0.130

0.388
0.302

-0.099
1.067
0.607

-0.495
0.387
0.560

0.296
1.746
0.654

0.623
0.002
< .001

-0.012
0.566
0.577

-0.246
0.162
0.533

0.223
0.971
0.622

0.923
0.006
< .001

Coeff = coefficient; UCI = upper confidence interval; LCI = lower confidence interval; RA = regional anesthesia; BPI = brief pain inventory; PTSD = post-traumatic stress disorder; Initial pain
presentation score= the same, initial BPI score corresponding to the outcome measure
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Table 3-4 (continued)
Coef.
1.230

Average Pain
LCI
UCI
0.977
1.483

No [Reference]
Yes
Month Since Injury
(0-24)
Change in PTSD Slope
Improving (¯)
[Reference]
Stable («)
Worsening ()
Injury Severity
Minor [Reference]
Moderate
Serious
Severe
Length of
Hospitalization (Days)
Marital Status
Single [Reference]
Married/Partnered
Separated/Divorced
Entry Cohort
≤ 6 Months [Reference]

-0.343

-0.511

-0.027

6 Months ≤ 1 Year
> 1 Year
First Pain Measure

Intercept
Regional Anesthesia

P-Value
< .001

Coef.
0.582

Pain Right Now
LCI
UCI
P-Value
0.308
0.857
< .001

Coef.
0.790

Interference
LCI
UCI
0.525
1.054

-0.175

< .001

-0.274

-0.471

-0.078

0.006

0.037

-0.149

0.224

0.694

-0.039

-0.015

< .001

-0.017

-0.032

-0.002

0.031

-0.037

-0.051

-0.024

< .001

-

-

-

-

-

-

-

-

-

-

-

-

-0.192
0.203

-0.474
0.034

0.089
0.371

0.180
0.018

0.145
0.373

-0.187
0.180

0.476
0.567

0.393
< .001

-0.511
-0.064

-0.822
-0.252

-0.200
0.124

0.001
0.504

-0.045
-0.049
-0.125

-0.269
-0.274
-0.388

0.178
0.175
0.138

0.690
0.666
0.350

-0.130
-0.028
-0.303

-0.390
-0.288
-0.608

0.129
0.232
0.003

0.324
0.833
0.052

0.148
-0.054
-0.064

-0.099
-0.302
-0.355

0.396
0.194
0.227

0.241
0.670
0.667

0.003

0.000

0.006

0.037

0.003

-0.001

0.007

0.134

0.005

0.002

0.009

0.002

0.116
0.089

-0.053
-0.255

0.285
0.433

0.179
0.612

0.201
-0.007

0.004
-0.406

0.398
0.392

0.046
0.972

0.456
0.766

0.271
0.385

0.641
1.147

< .001
< .001

-

-

-

-

-

-

-

-

-

-

-

-

0.191
0.741
0.581

-0.100
0.241
0.535

0.482
1.240
0.626

0.198
0.004
< .001

0.307
0.740
0.588

-0.057
0.106
0.542

0.672
1.375
0.634

0.099
0.022
< .001

0.099
0.547
0.578

-0.221
-0.004
0.539

0.419
1.097
0.617

0.544
0.052
< .001

P-Value
< .001

Coeff = coefficient; UCI = upper confidence interval; LCI = lower confidence interval; RA = regional anesthesia; BPI = brief pain inventory; PTSD = post-traumatic stress disorder; Initial pain
presentation score= the same, initial BPI score corresponding to the outcome measure
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Figure 3-1: PTSD Symptom Trajectories based on PCL-M Slope, examples

PTSD severity (Y Axis) by time of observation since injury (X Axis) with fitted least squares slope of
symptom trajectory
PTSD Symptom
Trajectories
PTSD Gets Worse
PTSD Remains
Stagnant
PTSD Improves

Last Observed
PCL-M Score
30

First Observed
PCL-M Score
17

Slope

Indicator Term

Positive (+)

Worsening PTSD

20

20

Zero (0)

Stable PTSD

17

30

Negative (-)

Improving PTSD
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Figure 3-2: Worst Pain by RA receipt

Figure 3-3: Least Pain by RA receipt
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Figure 3-4: Average Pain by RA receipt

Figure 3-5: Pain Right Now by RA receipt

92

Figure 3-6: Pain Interference by RA receipt

93

Figure 3-7: Worst Pain by PTSD Symptom Trajectory

Figure 3-8: Least Pain by PTSD Symptom Trajectory
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Figure 3-9: Average Pain by PTSD Symptom Trajectory

Figure 3-10: Pain Right Now by PTSD Symptom Trajectory
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Figure 3-11: Pain Interference by PTSD Symptom Trajectory
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Appendix
Table A3-1: Participant Observation Distributions
Observation #

Participants
N=288

Percent

2

26

9.03

3

32

11.11

4

35

12.15

5

26

9.03

6

35

12.15

7

35

12.15

8

28

9.72

9

23

7.99

10

32

11.11

11

10

3.47

12

6

2.08
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Table A3-2 Sensitivity Analysis with Adjusted PTSD Trajectory Caliber
Worst Pain

Least Pain

Average Pain

Pain Right Now

Pain Interference

Coef

LCI

UCI

P

Coef

LCI

UCI

P

Coef

LCI

UCI

P

Coef

LCI

UCI

P

Coef

LCI

UCI

P

1.88

1.49

2.27

0.00

0.40

0.21

0.58

0.00

1.16

0.90

1.41

0.00

0.53

0.27

0.80

0.00

1.05

0.76

1.33

0.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.15

-0.40

0.10

0.23

-0.21

-0.34

-0.08

0.00

-0.24

-0.41

-0.07

0.01

-0.15

-0.34

0.04

0.11

0.02

-0.17

0.22

0.83

-0.04

-0.06

-0.03

0.00

0.00

-0.01

0.01

0.50

-0.03

-0.04

-0.02

0.00

-0.01

-0.03

0.00

0.04

-0.04

-0.05

-0.02

0.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.28

-0.57

0.01

0.06

-0.06

-0.21

0.10

0.48

-0.23

-0.43

-0.03

0.02

-0.06

-0.28

0.16

0.62

-0.52

-0.76

-0.29

0.00

0.06

-0.23

0.36

0.68

0.17

0.02

0.31

0.03

0.31

0.11

0.51

0.00

0.44

0.22

0.65

0.00

-0.14

-0.36

0.09

0.23

0.00

-0.01

0.01

0.82

-0.01

-0.01

0.00

0.13

0.00

-0.01

0.00

0.34

-0.01

-0.02

0.00

0.02

-0.01

-0.02

0.00

0.21

0.01

0.01

0.01

0.00

0.00

0.00

0.01

0.01

0.01

0.00

0.01

0.00

0.00

0.00

0.01

0.03

0.01

0.00

0.01

0.00

Single [Reference]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Married/Partnered

0.43

0.19

0.68

0.00

0.05

-0.07

0.18

0.43

0.21

0.04

0.37

0.02

0.14

-0.04

0.33

0.14

0.52

0.33

0.71

0.00

Separated/Divorced

0.11

-0.43

0.65

0.70

-0.01

-0.28

0.27

0.96

-0.02

-0.39

0.35

0.92

-0.05

-0.45

0.36

0.83

0.55

0.14

0.96

0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6 Months ≤ 1 Year

-0.23

-0.68

0.23

0.33

-0.06

-0.29

0.18

0.64

0.08

-0.22

0.39

0.60

0.38

0.02

0.74

0.04

-0.13

-0.47

0.22

0.47

> 1 Year

1.04

0.28

1.80

0.01

0.60

0.21

0.99

0.00

0.72

0.21

1.23

0.01

0.79

0.18

1.40

0.01

0.41

-0.17

0.99

0.17

0.59

0.54

0.63

0.00

0.56

0.51

0.60

0.00

0.55

0.50

0.59

0.00

0.59

0.54

0.63

0.00

0.54

0.50

0.59

0.00

Intercept
Regional Anesthesia
No [Reference]
Yes
Month Since Injury
(0-24)
Change in PTSD
Slope
Improving (¯)
[Reference] [n=628]
Stable («) [n=636]
Worsening ()
[n=645]
Injury Severity
Score (continuous)
Length of
Hospitalization
(Days)
Marital Status

Entry Cohort
≤ 6 Months
[Reference]

First Pain Measure

Coeff = coefficient; UCI = upper confidence interval; LCI = lower confidence interval; RA = regional anesthesia; P=P-value; BPI = brief pain inventory; PTSD = post-traumatic stress disorder; Initial
pain presentation score= the same, initial BPI score corresponding to the outcome measure
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Figure A3-1: PTSD Checklist Scores and Worst Pain, by Month of Observation

Figure A3-2: PTSD Checklist Scores and Least Pain, by Month of Observation
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Figure A3-3: PTSD Checklist Scores and Average Pain, by Month of Observation

Figure A3-4: PTSD Checklist Scores and Pain Right Now, by Month of Observation
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Figure A3-5: PTSD Checklist Scores and Pain Interference, by Month of
Observation
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CHAPTER 4
Utilizing Markov Models to Illustrate Pain Transitions After Combat Injury
Abstract
Few longitudinal investigations of combat-injured American military personnel and
veterans examine the effects of acute pain management on long-term patient-reported
pain outcomes. Markov models are mathematical models that can be used to simulate
disease process in a series of states, such as describing how patients are likely to
transition from one pain state to another, in a probabilistic fashion. Utilizing data from
355 combat-injured military personnel, this modeling study characterized probabilistic
pain trajectories, stratified by either receipt of regional anesthesia (RA) or systemic pain
management after injury, across multiple dimensions of pain intensity (e.g. worst,
average, and pain right now). Findings show that individuals are likely to transition out of
states of severe and moderate pain to states of lower pain intensity or no pain. Transition
probabilities ranged from <1.00% from no pain to severe pain, to 75.00% for the
transition from a state of no pain to remaining in a state of no pain. While simulated
projections indicate differences in the probability of remaining in a state of severe or
moderate pain up to 24 months after injury by pain management intervention, there is no
statistically significant difference between the distributions by regional anesthesia (RA)
and standard systemic pain management approaches (worst pain, AD=0.2576, P=0.13;
average pain, AD=0.2348, P=0.21; pain right now, AD=0.1853, P=.82). Results indicate
that Markov modeling is a practical approach for describing probabilistic combat injury
related pain trajectories and can inform care planning beginning from time of acute pain
management.
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Introduction
Advancements in prehospital combat casualty care have contributed to reducing
preventable deaths on the battlefield,1 but have resulted in soldiers surviving with more
severe disabilities and significant problems with chronic pain. Yet, there is a dearth of
evidence regarding the long-term benefits of early pain management for survivors.
Ongoing pain assessment and management from the point of injury and throughout the
care continuum are thought to be key to mitigating risks for developing chronic pain.2
Despite resolution of the initial injury, maladaptive biopsychosocial mechanisms can
manifest in chronic pain, defined as persistent pain lasting over three months.3 Rates of
chronic pain in the United States (U.S.) Operation Enduring Freedom and Operation Iraqi
Freedom (OEF/OIF) care-seeking veteran population are estimated to be 28% to 47%,4
and up to 83% among polytrauma survivors (i.e. those with multiple affected body
regions and organ systems).5 Chronic pain experienced by veterans is associated with
lower physical function,6 increased risk of comorbid mental health conditions (e.g. posttraumatic stress disorder [PTSD]),7 increased healthcare utilization,8 and poorer quality of
life.9 The administration of multimodal analgesics in prehospital care and prior to
surgery is believed to reduce both peripheral and central sensitization caused by injury,
thereby lessening the onset of pain windup, a pathological process contributing to the
transition of acute to chronic pain.10-13
Timely and targeted delivery of pharmacotherapy in the aftermath of combat injury
has a demonstrated ability to reduce acute pain intensity.14 Yet, widespread patient
dissatisfaction with pain control after combat injury suggests acute pain management
after injury remains an important area of research.2 Early aggressive multimodal
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management of acute pain is essential to minimize the risk of developing chronic pain
after combat injury. The administration of systemic analgesics during trauma care has
been found to alleviate acute pain in a timely manner and even reduce the risk of
developing mental health conditions.15-17 However, these systemic approaches increase
risks for over sedation, respiratory depression, and vasodilation leading to hypotension
and additional blood loss,18 which can be life-threatening adverse events.
Analgesics and anesthetics delivered through a peripheral nerve block or epidural,
known as regional anesthesia (RA), have been shown to provide a more optimal
management of acute pain at the point of combat injury and throughout acute care in U.S.
military medical facilities.12,13,16,19,20 RA’s targeted delivery of multimodal analgesics has
lower risk of hypotension and hypoventilation than that seen in systemic medication
administration.18 Implementation of acute pain services, access to RA trained pain
providers in combat support hospitals, and adherence to pain management guidelines
have been shown to improve pain monitoring and relief after combat injury.11,16,21 Yet,
research designs examining the effects of acute pain management, specifically RA, in the
immediate aftermath of combat injury, transportation, and the intraoperative periods, are
generally cross-sectional, retrospective, or of limited duration, with many primarily
conducted in the acute phase of recovery.12,13,16,19,20 Evaluation of the long-term effects of
acute pain management is complicated due to the limited pain interventions available in
the austere environment, suboptimal recording of pain assessment and treatment
documentation throughout care, and challenges engaging survivors in research during
community reintegration.2,11,21 Given the complexities in studying outcomes after combat
injury, it is difficult to evaluate the longitudinal nature of pain trajectories. The recently
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completed Regional Anesthesia Military Battlefield Pain Outcomes Study (RAMBPOS)
collected data at multiple time points over the duration of 2 years after combat-related
injury and examined the effect of early acute pain management interventions after injury.
RAMBPOS participants provided patient-reported outcomes throughout recovery,
including measures of multiple presentations, or dimensions, of their pain experience.
The multiple dimensions include worst pain, least pain, average pain, and pain right now
at time of assessment.
Markov models are mathematical models that can be used to simulate disease process
that can be shown as a series of states, and pain trajectories happen to be such a process.
Markov modeling simulates randomly changing systems, or disease states, where the
future state is independent of the past and only dependent on the current state. This
modeling approach can provide insight into disease or condition specific behavior
represented based on a set of transitions. Markov models can be used to leverage
currently available pain intensity data sources, such as RAMBPOS, in order to generate
parameter estimates from which to draw samples of pain trajectories from large
theoretical combat-injured cohorts. Markov models are used extensively in costeffectiveness analyses to longitudinally project the benefits of pain interventions.22 The
key assumption of a Markov model is that transitions between states form a Markov
chain. As such, transitions to future states are dependent only on the current state and not
on any previous states. Markov chains represent repetitive events and time, such as
changes in pain intensity, using probabilities of future transitions. Tighe et al.
demonstrated the application of using Markov chains in illustrating acute pain transitions,
from no pain to severe pain, after surgery, using a one-dimensional numeric rating scale
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from 0 to 10.23 Additionally, Markov chains have been used to estimate long-term
differences in the cost of care for British military amputees after being injured in
Afghanistan.24 To our knowledge, no investigation has evaluated the effects of RA on
long-term pain trajectories after combat injury. The Markov chain approach enables the
computation of pain trajectories in a probabilistic manner, while also adjusting for acute
pain management interventions and time. The aims of this study are to 1) define
probabilities of pain trajectories after combat injury across multiple dimensions of pain
intensity, 2) stratify pain trajectories by RA receipt, and 3) estimate pain trajectories from
high pain intensity to low pain intensity. The benefit of this approach is that simulations
with Markov models can form the foundation of decision models that incorporate care
decisions and clinical outcomes, such as quality of life and costs in the future.
Methods
This modeling study utilized RAMBPOS participants’ data to estimate transition
probabilities. IRB approval for this study was provided by the Veteran’s Affairs Office of
Research and Development and the University of Pennsylvania.
Description of Data
RAMBPOS is a prospective observational cohort study of U.S. OEF/OIF military
personnel with major combat-related limb injuries and known receipt status to early
aggressive RA. By collecting patient-reported outcomes over the first two years after
combat injury, RAMBPOS provides one of the most comprehensive examinations of the
short- and long-term benefits of implementing early RA for pain control after major
traumatic limb injuries. Depending on the date and geographic location of injury,
individuals received RA in two ways, potentially. Either (1) upon arrival at a combat
112

support hospital in a forward operating base with a trained military RA provider deployed
at the time, or (2) based the availability of RA providers and acute pain services upon
arrival in a U.S. military hospital. Individuals receiving RA within two weeks after injury
in either of these conditions are part of the RA cohort. The No RA cohort consists of
participants who did not receive early RA within two months of injury. The No RA
cohort received standard systemic multimodal pain management throughout
transportation and acute care at U.S. military medical facilities.
The RAMBPOS dataset includes patient demographics, injury characteristics, RA
treatment and patient-reported pain outcomes. Participants were recruited and consented
during acute care and rehabilitation at two military medical facilities in the continental
U.S. Any military personnel with a combat-related major injury involving one or more
extremities and requiring hospitalization was eligible for enrollment. Eligible individuals
with cognitive deficits, moderate and severe traumatic brain injury (TBI), inability to
concentrate, poor judgment and impulse control, substantial hearing loss, and bilateral
upper extremity amputation with no alternate means to complete the survey forms were
excluded. After eligibility screening and consent, individuals could enter the study at any
time within the first two years after injury. Between October 2007 and September 2014, a
total of 386 individuals were enrolled. Medical records in the Department of Defense
(DOD) Trauma Registry, provided clinical and military career information, including
injury characteristics, sociodemographic information, and RA receipt status. Patientreported outcomes, including the Brief Pain Inventory (BPI), were collected monthly
within the first 6 months after injury and every 3 months after, up to 24 months after
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combat injury. Only participants with two or more complete BPI observations were
included in this analysis, for a total of 355 eligible participants.
The Brief Pain Inventory (BPI) is a 9-item pain assessment tool measuring pain
intensity and interference.25,26 The BPI measures the multidimensional nature of pain
intensity, specifically worst pain, average pain, and pain right now. Worst pain refers to
the most intense pain experienced in the past 24 hours, measured from 0, “no pain” 10,
“pain as bad as you can imagine.” The BPI average pain measure is an individual’s
reflection of the routine pain they experienced in the past 24 hours, whereas pain right
now refers to pain experienced at time of assessment using the same 0 to 10 scale.
Leading experts from the Initiative on Methods, Measurement, and Pain Assessment in
Clinical Trials (IMMPACT) panel recommended that all measures of pain intensity,
rather than just current pain, be included as outcomes in chronic-pain clinical trials.27 The
BPI was chosen for the analysis because of its brevity, its capability to capture multiple
dimensions of pain intensity, and its frequency of administration in the parent study. For
each BPI pain intensity score, the time since injury (measured in months) was calculated
to create a common reference point. Using 3-subscales of the BPI (worst pain, average
pain, and pain right now), we defined 4 pain states: no pain, mild pain, moderate pain,
and severe pain (Figure 4-1). These states correspond to established pain intensity
classifications from BPI scores: none (0), mild (1-4), moderate (5-6), and severe (7-10).28
This categorization by pain intensity rating was compared to an expanded multiple
objective state categorization utilizing the 0 to 10 BPI responses. The utility of the
expanded form in long-term clinical care and medical decision-making is questionable,
and therefore, the four-pain state approach was determined to be best for this analysis.
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Pain state is defined by an individuals’ BPI pain intensity (e.g., average, worst, and pain
right now) scores at any given month after injury. The transition from one pain state to
another (even if remaining in a specific state) over time, refers to individuals’ changes in
BPI pain intensity scores. These transitions, when examined over time, are considered the
pain trajectory. Individuals can only be in one pain state, over one discrete time period,
per trajectory. However, across pain trajectories individuals can be in different pain states
(e.g. in severe worst pain at one month and in mild average pain during that same month).
The RAMBPOS’ BPI data were used to obtain the probability of transitioning between
each pain state for patients receiving RA compared to No RA. In total, three pain
trajectories were constructed and then stratified by RA receipt status. The BPI measure
for least pain was excluded from the modeling after assessing distribution was almost
exclusively a score of 0 or 1.
Defining the Markov Chains and Transition Matrices
Markov models are mathematical predictions of recursive decision trees that are used to
model conditions with events that may occur repeatedly over time, such as pain intensity.
Markov models explicitly account for the passing of time, in the case of this analysis each
month since injury, and values of pain intensity at designated time points throughout the
study. Pain intensity values are discrete and measurements occur at regular intervals
which is a criterion for modeling as a stochastic process, using Markov chains. In terms
of Markov chains, future transitions are based on the present state of an individual and
are independent of past transitions or states.29 An individual’s history of BPI score
derived pain states does not influence their next or future transitions in this analysis.
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Collectively, the pain states and their associated probabilities in Markov chains are
presented as a transition matrix.
The transition matrix provides insight as to how combat-injured individuals move
across pain states in a probabilistic manner. In the transition matrix, the rows represent
the current state of the individual, and the columns represent future states. Using a long
file, with separate records for each repeated measure by a RAMBPOS participant,
individuals’ monthly movements from one pain state to another were counted using an
algorithm. Probability parameters were derived by summing the total transition count (the
number of time transitions) from one pain state (row) to an another (column), all divided
over the sum of the row’s count. One of the goals of acute pain management is to move
patients from a state of high pain intensity to a state of lower intensity. A prolonged
length of stay, up to three months, in a state of high pain intensity (moderate or severe)
were considered chronic pain for the purpose of this analysis. Transitions were modeled
in monthly increments. The Markov chain allows for the evaluation of movement across
states in a series of steps by multiplying the probability of moving from a row specified
state by the probability of a column state raised to the number of months. Stationary
distributions derived from the Markov chain probabilities allow for side by side
comparison between stratified groups, such as RA and No RA. Similarly, the number of
transitions needed, or time in which individuals move from high pain intensity to low
pain intensity states can be compared.
Results
Overall, RAMBPOS participants were young (28.00 years old, [Standard Deviation] +/7.1), male (99.20%), non-Hispanic (87.40%) and white (77.50%) (Table 4-1). Injury
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severity was measured using the Injury Severity Score (ISS), a numeric rating scale
where 75 indicates the greatest severity and death, and 0 is equal to no injury. More than
half the sample experienced serious (32.6%) or severe injuries (22.70%), with an average
injury severity score of 18.40 (+/- 10.8). Length of acute hospitalization was about 37
days, on average (+/- 33.4). The average number of deployments in this sample was 2
(+/- 1.3). In this subsample, 185 participants received RA, and 170 did not, known as the
No RA group. Three quarters of participants entered the RAMBPOS ≤ 6 months after
injury (75.80%). Table 4-2 provides sample characteristics of the RAMBPOS
participant’s pain transition data used for this analysis. In total, 2,214 pain observations
provided from 355 participants were used to calculate transition probabilities. About half
of the observations were from participants who had received RA (51.90%) and the other
half from those who did not receive RA (48.10%).
Overview of the Transition Matrices
The value of condensing pain states from 11 discrete states (0 to 10), to 4 (none, mild,
moderate, severe) is that movement across states requires larger incremental changes in
pain intensity and is not as sensitive to small, and less clinically meaningful, changes.
The condensed states, using worst pain as an example, provides an observable trend in
transition probabilities. The worst pain transition matrix is positive recurrent and
irreducible with no absorbing state. Individuals can transition from any pain state to
another, with a probability as low as 1.00% and as high as 65.00% (Figure 4-2). The
strongest probabilities are individuals transitioning from their current state and remaining
there, with a probability of 49.00% to 65.00% (i.e. the diagonal of the table). However, in
the average pain matrix individuals are rarely in a state of severe pain and remain there
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with probabilities from 0.00% to 8.0% (Figure 4-3). Similarly, individuals in severe pain
right now infrequently remain in a state of severe pain (probabilities 0.00% to 16.00%).
In the pain right now matrix, individuals have a higher probability to quickly transition
from severe to moderate pain states (43.00%) and from moderate to mild pain states
(59.00%). This indicates individuals gravitate towards lower pain states when reporting
pain right now.
Characterization of Stationary Distributions by RA
Transition matrices for worst pain, average pain, and pain right now were stratified by
intervention status (RA vs. No RA). Initial distributions across pain states by RA status
are displayed Table 4-3. Initial distributions are provided by the RAMBPOS cohorts and
their clinical pain presentations in the study. Figure 4-4 compares the stationary
distribution for worst pain by RA and No RA. There was no statistically significant
difference in the distributions by intervention (Anderson-Darling [AD] = 0.2576, P =
0.13). Based on the initial distribution provided by the RAMBPOS, after two years, or 24
monthly transitions, there is a 18.60% probability that individuals who did not receive
early RA will be in state of no pain, 28.90% in a state mild pain, 38.00% in moderate
pain, and 14.5% severe pain. Alternatively, there is only a 10.10% probability for those
who receive early RA to be in a state of no pain, 30.60% in a state in mild pain, 45.40%
in moderate pain, and 13.90% in severe pain (Figure 4-5).
The distributions were not statistically different by RA status, both for average pain
and pain right now (AD = 0.238, P = 0.21; AD = 0.1853, P > 0.82, respectively). Based
on the transition matrix for average pain (Figure 4-6) individuals receiving RA have a
probability estimate of 24.10% to be in no pain, 56.90% in mild pain, 18.40% in
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moderate pain, and only 0.60% in severe pain up to 2 years after injury. Overall,
individuals who do not receive RA have a probability of 28.70% to be in no pain, 47.80%
in mild pain, 23.20% in moderate pain, and 0.39% in severe pain (Figure 4-7). The
transition matrices for pain right now (Figure 4-8) indicate a probability of 35.30% in no
pain, 55.00% in mild pain, 8.70% in moderate pain, and only 1.00% in severe pain at 24
months post-injury and after receiving RA after 24 months (Figure 4-9). Alternatively, a
larger probability exists for individuals not receiving RA to be in no pain right now,
44.80%, but also a slightly larger probability to be in severe pain, 2.30%. At 2 years after
injury individuals without RA have a 46.90% probability of being in mild pain right now
and 6.00% in moderate pain right now.
The most prominent transition occurs within the first 6 months after injury and
provides an opportunity to examine the movement from severe acute pain to no pain
(Figures 4-10, 4-11, 4-12). For example, if all combat-injured individuals (100% of a
given sample) are assumed to be in severe average pain within the first month after
injury, there is a 58.70% probability that combat-injured persons receiving RA are
estimated to transition to mild or no pain within 3 months. Whereas, only a 52.70%
probability for individuals not receiving RA to be in average mild or no pain in that same
transition time of 3 months. This translates to less than a quarter (23.90%) of RA
recipients being in chronic moderate or severe average pain at 6 months, compared to a
third (30.70%) of individuals who did not receive RA. This projection can continue out to
24 months, for participants who did receive RA the probability of remaining in chronic
moderate or severe pain is less than a fifth (19.00%) as opposed to a 23.00% probability
among participants not receiving early RA. However, this trend of RA individuals
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transitioning out of severe or moderate pain faster does not hold for pain right now. A
higher proportion of individuals who received RA remain in chronic moderate or severe
pain at 3 months (18.40%, RA; 15.70%, No RA), 6 months (11.50% RA; 9.60% No RA),
or 24 months (10.80% RA; 8.30% No RA). There is a slightly smaller estimated
probability for RA recipients to experience moderate or severe worst pain (72.40%) than
those without early aggressive RA (73.30%) in the first 3 months after injury. Yet, there
is a higher probability for individuals receiving early RA to experience moderate or
severe worst pain at 6 months (62.20%) and 24 months (59.30%) in comparison to the No
RA cohort (59.90%, 6 months; 52.50%, 24 months).
Discussion
The findings of this study demonstrate how individuals move across pain states after
combat injury using Markov chains to visualize the transition from moderate and severe
acute pain to moderate and severe chronic pain. Early pain trajectories, in the initial
months after injury, have the potential to inform researchers and providers of individuals
likely to develop future chronic severe or moderate pain.30 These trajectories can inform
the proactive and timely delivery of acute pain management interventions that not only
control pain but also prevent long-term moderate or severe chronic pain from developing.
Modeling symptom trajectories and responses to management interventions can inform
the design of future pragmatic trials that utilize successful interventions. The utility of the
Markov chain approach can be seen in the use of projecting possible clinical pain
presentations after combat injury. For this evaluation Markov chains modeled pain state
transitions by both initial presentations of the true RAMBPOS sample as well as
generating estimates based on proposed initial clinical presentations. For the latter,
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simulations were based on the assumption that all participants in a hypothetical combatinjured population present with severe pain within the first month after injury. In these
projections individuals in severe average pain or pain right now quickly transition to
lower pain intensity states within 3 and 6 months after injury. However, there is
probability that individuals, both those receiving RA and No RA, remain in chronic
severe or moderate average pain up to two years after severe injury. This sustained
absorption and steady proportion of individuals in the higher pain intensity states
highlight the need for continued assessment and management of all combat-injured
veterans.
Acute pain trajectories have been used as predictors of the future development for
chronic pain after acute tissue trauma, such as surgery. Others have examined the utility
of linearly predicting acute pain, specifically following surgery, but are limited to a few
days or months at a time and do not evaluate the long-term nature of chronic pain
transitions.30-32 Similar to other analyses of pain trajectories, the findings of this study
confirm the general improvement of pain intensity over time.30,31,33,34 However,
improvements are not necessarily linear in nature as proposed in the past. Understanding
pain trajectories with higher precision than what simple linear fits are able to provide, are
needed.30 Markov models allow the characterization of individual’s pain trajectories
through transition states and thereby able to identify abnormal acute pain resolutions.
These unaddressed abnormal resolutions can present as stable prolonged time spent in
moderate or severe chronic pain after 3 to 6 months. Tighe et al.’s probabilistic Markov
chains demonstrate the utility of stratifying patients into risk groups for increased pain
intensity based on their clinical characteristics.23 Despite their larger sample size (N=
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476,108), the author’s do not account for pain management interventions patients receive.
Althaus et al. followed patients up to six months after surgery to project long-term
transitions from acute to chronic pain, but again did not consider initial acute pain
interventions. This analysis uniquely evaluated pain trajectories after combat injury
stratified by RA status using a probabilistic approach. Additionally, this evaluation offers
an overview of the longitudinal transitions of pain across multidimensional pain
outcomes (e.g. worst pain, average pain, and pain right now), unlike other analyses that
are limited to only acute post-operative pain trajectories and current pain intensity
presentations.
Longitudinal studies examining pain trajectories over weeks and months after early
pain management are important in order to describe how pain changes as severe physical
injuries resolve.35 This lack of literature may be due, in part, to the inherently
unpredictable nature of trauma and the focus of controlling pain rather than preventing
pain from occurring.36 Studies examining severely injured civilian populations have
reported that pain can affect individuals up to 36 months after injury.37 Moreover,
elevated pain intensity immediately after injury is strongly associated with chronic pain
in civilian populations with lower extremity injures.35 The retrospective nature of much
of this body of injury and pain trajectory research emphasizes the need for prospective
studies. This probabilistic modeling provides a possible means by which to illustrate pain
trajectories utilizing existing pain data sources from clinical trials, such as RAMBPOS,
and health records.
In this secondary analysis, RA and systemic pain management approaches were
shown to be effective in reducing length of time spent in severe and moderate pain after
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injury. While differences in probability transitions were found between RA groups, they
did not reach statistical significance. RA distributions were not statistically different from
No RA probability distributions. RA is an established multimodal pain management
intervention demonstrated to improve acute pain, one of the largest risk factors for
developing chronic pain, after combat injury in Iraq and Afghanistan.12,13,16,19
Researchers have confirmed the improvements of RA over systemic analgesics on
improving health outcomes after injury.38-40 Further, a meta-analysis of civilian surgical
patients indicated that epidural anesthesia and blocks help prevent chronic postoperative
pain up to one year after surgery.41 Studies examining the benefits of RA in combat
injured populations beyond acute care are limited in availability; possibly due to the
highly transient nature of military personnel and veterans after discharge as they return to
their civilian lives. While there was no statistically significant difference in the
probability distributions between RA and No RA, this analysis was the first to
demonstrate the utility of using Markov chains to model pain transitions after combat
injury in OEF/OIF military personnel and veterans. For example, transition matrices
indicate the utility of RA in reducing the proportion of individuals in prolonged severe
and moderate pain within a few months after combat injury up to two years later. This
work estimates necessary underlying probability parameters to build future Markov
models that incorporate utility values for quality of life, and even cost.
Limitations of this analysis include the nature of the clinical data used and the
assumptions needed to utilize Markov chains. Despite RAMBPOS being one of the
largest and most comprehensive dataset of patient-reported pain outcomes after combat
injury, there are a limited number of observations compared to other’s analyses of pain
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outcomes using Markov models.23 Given the limited number of observations, transition
probabilities for the matrices were evenly populated from observations by RA and No
RA cohorts. Future analyses should be conducted on more robust datasets of pain
outcomes. Inherent limitations of the Markov chain include assumptions of independence
that may defy the true nature of pain. For example, an individual’s pain intensity
responses may be influenced by their previous pain intensity and therefore not
independent to predict future pain intensity. Further, these Markov transitions evaluated
differences by RA receipt, and did not consider underlying factors that can influence an
individual’s pain intensity, such as mental health diagnoses. Approximately a quarter of
the data utilized for this analysis were generated by individuals who joined RAMBPOS
more than six months after injury. Therefore, it is important to note that those participants
joining later have inherently less follow-up time than those enrolled earlier after injury
and could have poorer pain outcomes on which average probability transitions were
estimated. However, RAMBPOS is one of the first longitudinal studies measuring
patient-reported pain outcomes after combat injury and evaluating acute pain
management interventions. Therefore, this work is exploratory in nature and provides the
parameters for future modeling work in the regards to conducting cost-effectiveness
analyses with analgesic interventions. In the future, Bayesian approaches can be
incorporated to calibrate model parameters and probabilistic distributions to overcome
these limitations if a large enough sample of longitudinal pain intensity measures can be
obtained.
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Conclusion
In conclusion, the unique features of the Markov model enable evaluation of pain
intensity trajectories after combat injury. Moreover, this analysis captured the
multidimensional nature of pain intensity, as opposed to a single 0 to 10 assessment of
current pain intensity at time of observation. Findings indicate that individuals receiving
RA transition quickly out of severe and moderate average pain intensity in the first six
months after injury compared to No RA individuals, however, there was no statistically
significant difference in the probability distributions. This research provides foundational
findings that can be leveraged for future cost-effectiveness analyses, that in turn can
contribute to better understanding of the benefits of RA after combat injury.
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Figure 4-1: Visualization of the Markov model’s pain states (circles)
with transition pathways (arrows)
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Table 4-1: RAMBPOS Subsample Characteristics
Total
N=355
Age
Mean
Std. dev.
Number of Deployments
Mean
Std. dev.
Length of Stay in Hospital
Mean
Std. dev.
Injury Severity Score
Mean
Std. dev.

28
7.1
2
1.3
36.7
33.4
18.4
10.8
%

ISS Category
Minor (£9)
Moderate (10-15)
Serious (16-24)
Severe (³25)
Time Since Injury to Entering Study
≤ 6 Months
6 Months ≤ 1 Year
> 1 Year
Regional Anesthesia
Yes
No
Sex
Female
Male
Race
White
Black
Other
Ethnicity
Hispanic
Non-Hispanic

75.80%
14.30%
9.90%

N
75
83
116
81
269
51
35

52.11%
47.89%

185
170

0.80%
99.20%

3
352

77.60%
5.30%
17.10%

276
19
60
44
311

21.20%
23.50%
32.60%
22.70%

12.60%
87.40%

Std. dev=standard deviations; ISS= Injury Severity Score; HS= High School
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Table 4-2: RAMBPOS Participant Data for Markov Model
Variables
Worst Pain (BPI Score)
None (0)
Mild (1-4)
Moderate (5-6)
Severe (7-10)
Average Pain (BPI Score)
None (0)
Mild (1-4)
Moderate (5-6)
Severe (7-10)
Pain Right Now (BPI Score)
None (0)
Mild (1-4)
Moderate (5-6)
Severe (7-10)
Regional Anesthesia
Yes (n=185)
No (n=170)
BPI=Brief Pain Inventory
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Observations
(N=2214)

Percent

217
865
467
665

9.8%
39.2%
21.1%
30.0%

437
1450
270
57

19.8%
65.5%
12.2%
2.6%

796
1180
184
54

35.9%
53.3%
8.3%
2.4%

1150
1064

51.9%
48.1%

Figure 4-2: Illustration of Expanded to Condensed Pain States
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Figure 4-3: Transition Matrices of Average Pain and Pain Right Now
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Table 4-3: Initial Pain State Distributions from RAMBPOS (N=385)
Worst Pain

Average Pain

Pain Right Now

RA

No RA

RA

No RA

RA

No RA

No Pain

4.8%

9.4%

11.8%

12.9%

25.3%

12.9%

Mild

28.0%

34.7%

68.8%

65.9%

56.5%

65.9%

Moderate

31.7%

18.2%

14.5%

15.9%

12.9%

15.9%

Severe

35.5%

37.6%

4.8%

5.3%

5.4%

5.3%
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Figure 4-4: Transition Matrices of Worst Pain, by Regional Anesthesia
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Figure 4-5: Projected Pain Transitions by Regional Anesthesia, Worst Pain
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Figure 4-6: Transition Matrices of Average Pain, by Regional Anesthesia
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Figure 4-7: Projected Pain Transitions by Regional Anesthesia, Average Pain
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Figure 4-8: Transition Matrices of Pain Right Now, by Regional Anesthesia
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Figure 4-9: Projected Pain Transitions by Regional Anesthesia, Pain Right Now
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Figure 4-10: Projected Pain Transitions Beginning from Severe Pain by Regional Anesthesia, Worst Pain
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Figure 4-11: Projected Pain Transitions Beginning from Severe Pain by Regional Anesthesia, Average Pain
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Figure 4-12: Projected Pain Transitions Beginning from Severe Pain by Regional Anesthesia, Pain Right Now
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Appendix
Below, !" is a general discrete time Markov chain with a transition matrix, #(%, '), for any
state between % *+, '
- !"./ = ' !" = %. !"2/ = %"2/ , … , !4 = %4 ) = #(%, ')
In other words, the probability of moving from one state to another state, in one time
cycle, is only dependent on the present state, thereby making the past transitions
irrelevant.
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CHAPTER 5
Discussion
Adequate pain management after combat-related injury is essential to ensure optimal
physical and mental health recovery. While multimodal pain management using regional
anesthesia (RA) was a vital component of the military’s pre-hospital and acute care pain
management protocol for personnel injured in OEF/OIF conflicts, the long-term benefits
of RA have not been well-researched in this population. Therefore, the overall goal of
this dissertation was to use a biopsychosocial perspective to identify the complex and
interrelatedness of pain and post-traumatic stress disorder (PTSD) symptom severity
while also evaluating the short- and long-term associations of early pain management
after combat related-injury on pain intensity and interference. Chapter 2 of this
dissertation synthesized presentations of pain, PTSD, and depression after combat-related
injury and highlighted that timely pain management, in addition to controlling acute pain,
is associated with reduced mental health symptoms after polytrauma. Informed by the
established relationship between pain and mental health symptom presentations in
combat-injured military personnel and veteran populations, Chapter 3 evaluated the
association of RA and PTSD symptom trajectories with pain intensity and interference in
a sample of combat-injured OEF/OIF military personnel and veterans. Chapter 4
examined pain trajectories after combat injury in a probabilistic manner, while stratifying
by early RA receipt status.
This dissertation contributes to the existing knowledge of providing adequate pain
management for combat-injured military personnel and veterans while assessing the
optimization of analgesic and anesthesia delivery via RA, which will inform future
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research. The ability to expand science in the use of early aggressive acute pain
management with RA, and its impact on long-term pain outcomes will be invaluable for
future trauma responders and clinicians managing acute pain to prevent the development
of chronic pain and possible disability.
Major Findings of Chapter 2
There is a paucity of studies examining the interrelatedness of pain, PTSD, and
depression associated with combat injury. This integrative review of twenty-two peerreviewed publications examined the complex relationship between pain, PTSD, and
depression in combat-injured veterans and military personnel who served in OEF/OIF.
Findings indicated that greater pain severity poses risks for developing PTSD following
combat injury in this specific population. Moreover, early pain management may lessen
the risk for developing PTSD. Following combat injury, depression can be a comorbidity
of and a contributing risk factor to PTSD. The foundation of cross-sectional research
examining pain, PTSD, and depression symptoms highlights the need for further analysis
of these longitudinal relationships in combat-injured military personnel and veterans.
The body of literature in this integrative review examining clinical presentations after
combat injury demonstrated a compelling demand for improvements in the continuity of
assessments of pain and mental health symptoms across transitions in care. There are
limited longitudinal studies investigating the prolonged surveillance of symptoms after
combat-related injury that is further hindered by limited use of standardized assessment
tools. The cross-sectional nature, on which existing research is built upon, does not
account for the time since initial injury or consider the utilization of repeated patientreported outcome measures across settings where combat-injured veterans access health
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care. Future research efforts should include ongoing assessments with standardized
measures in studies that investigate the relationship of pain and mental health beyond
acute care and throughout recovery.
Major Findings of Chapter 3
This secondary analysis was one of the few longitudinal studies examining the
association of early acute pain management, PTSD symptoms and pain outcomes after
combat-related injury. Findings highlighted the positively correlated monotonic
association between PTSD symptom severity and, pain intensity and interference up to
twenty-one months after combat injury. Individuals receiving RA experienced lower pain
intensity, even after controlling for injury severity and time from injury to observation
using a mixed effect model. This association suggests that the delivery of analgesics and
anesthetics using peripheral nerve blocks or epidurals improve short- and long-term pain
intensity and interference after combat injury. Moreover, PTSD symptom trajectories,
specifically military personnel and veterans with worsening PTSD, are associated with
small statistically significant increases in average pain intensity and pain right now. This
emphasizes the value of RA in the immediate after math of injury and throughout
recovery. There is a need for continued evaluation of pain-related outcomes and
comprehensive mental health treatment approaches beyond one year after injury. The
association between pain and PTSD symptom trajectories, following combat injury, can
inform providers that fluctuation is PTSD requires extensive assessments of pain
intensity.
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Major Findings of Chapter 4
In order to effectively manage acute pain intensity after injury, timely and targeted pain
management is essential; however, less is known regarding how pain management
interventions influence future post-injury pain trajectories. Efforts to evaluate pain
trajectories after combat injuries are further impeded by missing data and possibly that
personnel are lost to follow up as they transition out of their active duty military roles and
back into their communities. A Markov chain approach was used to generate probabilistic
transition matrices of pain trajectories after combat injury across multiple dimensions of
pain intensity. The rationale for this using approach includes the capability of Markov
models to explicitly account for the timing of events and state transitions, whereas time is
often less explicitly accounted for in standard decision trees and clinical trials. This
allows for modeling beyond the duration of the study data collection period. Findings
from this secondary analysis showed that both RA and systemic pain management
approaches were effective in reducing length of time spent in severe and moderate pain
intensity after injury. There were more pronounced changes in the first six months after
injury with individuals expected to have higher probabilities to move from states of high
pain intensity, encompassing severe and moderate pain, to stabilize in states of mild or no
pain, compared to beyond six months. This work provides the necessary underlying
probabilistic parameters on which to build future simulated Markov models that
incorporate costs and quality of life after injury to determine clinical and costeffectiveness.
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Limitations
It is important to note several limitations of this dissertation. The study’s secondary
nature hinders the ability to demonstrate causation of RA to improve pain intensity or
interference. It does however, afford an important opportunity to examine the
associations between early pain management approaches, PTSD symptom trajectories,
and pain outcomes. The RAMBPOS dataset is the only longitudinal investigation of
comprehensive patient-reported outcomes from the time of acute care and up to two years
after combat injury. Therefore, this observational approach is a rare opportunity to
evaluate how RA administration is associated with changes in pain intensity. This
research did not examine the specific symptom criteria of PTSD, but instead examined
total symptom severity and, uniquely, PTSD trajectories after combat injury. Changes to
diagnostic criteria for PTSD assessment tools, such as the PCL-M, since the RAMBPOS
data collection period makes it impossible to evaluate new diagnostic criteria (i.e.
alterations in cognitive states and mood). Despite this challenge, the PCL is widely used
in the literature and updated DSM-5 PCL instruments perform similarly in accurately
capturing the prevalence of PTSD in OEF/OIF veterans.1 The RAMBPOS was
exclusively comprised of OEF/OIF military personnel and veterans, however findings of
this research can inform the acute pain management care needs of civilian polytrauma
cohorts. The symptom trajectories of civilian survivors of trauma and the effects of acute
pain management interventions have not been extensively studied beyond acute care
discharge. Civilian trauma care can be more comprehensive, in a way that accounts for
the longitudinal trajectory of pain and mental health symptoms from the time of injury
and throughout acute care. Developing adequate pain management protocols in trauma
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care with long-term optimal recovery in mind will depend on leveraging findings from
pre-existing datasets of patient-reported outcomes from injured military personnel and
veterans. Moreover, the ability to expand science in the use of early aggressive acute pain
management with RA, and its impact on long-term pain outcomes can be invaluable for
future trauma responders and clinicians in civilian settings.
Implications
Implications of this research include the continuation of leveraging research of military
advancements for trauma related pain to meet the pain management needs of severely
injured civilians. The measures taken to ensure preservation of life after complex injuries
require innovations of care commensurate with the extensiveness of bodily harm.
Therefore, advancements made in trauma care are inextricably linked to war.2 This
includes the many modern clinical interventions used in civilian trauma care, which
originated from the military. These trauma care improvements include the use of
tourniquets to reduce mortality from hemorrhage, effective antimicrobial use for wound
care to prevent infection, and helicopters for rapid transport after trauma in civilian health
systems.2,3 The use of these care advancements and other technical developments (e.g.
protective body armor) have enabled trauma providers to preserve life after devastating
injuries. In spite of the severity of injuries, case fatality rates among American military
personnel are half those seen in previous armed conflicts (7.1%, OEF/OIF; 15.8%,
Vietnam War).4,5 The improved survival of critically ill trauma patients necessitated
greater attention be paid to pain management from the point of combat injury and beyond
throughout OEF/OIF. The delivery of multimodal anesthesia and analgesia via peripheral
nerve blocks (i.e. RA) have been efficacious in the current military conflicts in providing
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adequate and safe uninterrupted pain management after polytrauma and reducing future
chronic pain intensity, as seen in this dissertation.
Other trauma care advancements, including RA for continuous optimal multimodal
pain management, have had less penetration into the civilian sector. The use of
indwelling nerve catheters has transformed pain control for combat-related extremity
injuries since the Vietnam War.6 Up to 57% of OEF/OIF military personnel with combatrelated extremity injuries receive pain management in the acute care period via RA.6,7
Unfortunately, RA techniques have not been widely incorporated within civilian
emergent care settings.8 In the 2016 report titled, A National Trauma Care System:
Integrating Military and Civilian Trauma Systems to Achieve Zero Preventable Deaths
After Injury,8 the National Academy of Medicine identified:
“Lessons learned by U.S. military personnel that improve the care and recovery of
service members injured on the battlefield have been neither thoroughly nor
adequately disseminated throughout the military, nor have they been translated
reliably into civilian trauma care. The result has been many thousands of instances of
preventable death and needless disability across the two sectors, along with
excessive costs”9
The demonstrated success of RA for pain management in the combat theater, in transport,
and throughout surgical and acute care cannot be neglected in the interwar period.10-12
The ability to expand science in the use of early aggressive acute pain management with
RA, and its impact on long-term health outcomes, will be invaluable for future trauma
responders and clinicians managing acute pain to prevent the development of pain, pain
interference and associated disability after serious injury. Civilian care and military
personnel and veteran trauma care do not exist in silos.
Now more than ever, it is necessary to translate military trauma pain care into the
civilian healthcare sector as domestic terrorist attacks and mass shootings produce
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injuries akin to those of battlefield trauma. The increasing incidence of domestic mass
casualty incidents, including the horrific events at the Boston Marathon (Massachusetts,
2013), Orlando Night Club (Florida, 2016), Las Vegas (Nevada, 2017), and Marjory
Stoneman Douglas High School (Florida, 2018), calls for urgency in adopting military
casualty pain care. Despite the surge in lethality of these recent attacks, it is important to
recognize that there are many more survivors. These survivors can possibly suffer from
devastating and debilitating injuries that would benefit from early aggressive pain
management in similar ways to military combat pain care. For example, retrospective
profiles of wound patterns in civilian public mass shooting incidences identified that as
much as 20% of victims sustain extremity injuries.13 Pain has been found to effect up to
50% of severely injured civilians nearly three years after acute trauma care.14
Additionally, as much as 23% to 28% of injured civilians requiring trauma care develop
PTSD within one year of injury.14,15 The frequency of these events and severity of
injuries sustained by survivors require trauma providers be able to provide timely pain
management interventions.
The frequent co-occurrence of pain and PTSD after injury elicits a need for dual
management of conditions throughout injury related care, beginning in pre-hospital and
acute care. Uncontrolled pain and increased pain after injury is associated with an
increased risk for developing PTSD.16-18 Further, immediate pain management in
combat-injured military populations is associated with reduced risk of developing PTSD
after injury.19 Clinical presentations of pain and PTSD after injury, coupled with the
continued necessity of administering optimal analgesic medication in acute trauma care
settings, furthers the need for exploration of using RA for providing adequate pain
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control. Additional research is needed investigating how pain trajectories can influence
future mental health symptom severity. This dissertation found that the application of RA
and systemic pain management approaches reduce the amount of time spent experiencing
high pain intensity and reduce long-term pain intensity after experiencing severe injuries.
It is imperative that clinicians and researchers continue the translation, implementation,
and evaluation of RA in civilian trauma settings.
Future Directions
Advancing the use of RA in civilian trauma care settings will require continued
longitudinal research of severely injured persons and expanded opportunities for
anesthesia and pain management providers to be trained in RA techniques. Future
research in this line of inquiry must recognize the importance of the relationship between
physical symptoms and psychological symptoms, as framed by the Biopsychosocial
Model for Chronic Pain, after injury. Therefore, assessment of pain and mental health
symptoms that extends beyond acute trauma care is essential to expand current
knowledge of how findings from this research relate to civilian populations. Additionally,
further prospective research examining the effects of RA on PTSD symptom severity,
specifically if there is an association with a reduction in symptoms. These future
investigations will require that patient-centered trauma care combine immediate survival
treatment with consideration of long-term needs of pain management and mental health
support. Doing so will depend on injured civilians having access to effective pain
management approaches, such as RA. This requires coordinated efforts within health
systems to ensure anesthesia providers are appropriately trained in RA administration.
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Findings from this research may have the ability to advance the science to
promote the science behind the care of certified registered nurse anesthetist (CRNA) led
RA treatments for all traumatically injured persons. CRNAs are well positioned in many
acute trauma care settings and can leverage their clinical training to incorporate effective
pain management across the continuum of care for injured persons.20 However, the
proportion of time spent in of training for anesthesia providers to practice administering
RA has not expanded since 199021 even as the number of patients requiring care for
severe injuries has increased and as have the total associated costs in the United States
(U.S.).22 In light of this growing proportion of injury survivors and swelling costs of both
pain and trauma in the U.S., there is a compelling need to determine the clinical and costeffectiveness of RA after injury.22,23 Future work evaluating the cost-effectiveness of RA
over systemic analgesia after injury is necessary to advancing trauma care.
Demonstrating the effectiveness of CRNA led RA administration has the potential to
support policies expanding training opportunities and scope of practice for CRNAs in
order to optimize pain management for injured persons.
Conclusion
In conclusion, this dissertation contributes to current understandings in the short- and
long-term care requirements of combat-injured military personnel and veterans serving in
OEF/OIF. There is a complex relationship between pain and mental health symptoms,
specifically, PTSD, after serious combat injury. There is a significant positive
relationship between patient-reported pain outcomes, both pain intensity and interference,
and total PTSD symptom severity up to twenty-one months after combat injury.
Worsening PTSD symptom trajectories are associated with experiencing more intense
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average pain and pain right now after combat injury compared to individuals with
improving PTSD trajectories. Individuals receiving RA experience less intense pain after
injury than individuals not receiving RA. Markov modeling projected pain trajectories
individuals may experience after combat-related injuries. Moreover, when stratified by
receipt of RA and systemic pain management approaches there is a pronounced
movement from high pain intensity to low pain intensity in the first six months after
injury. This dissertation highlights the importance of sustaining efforts to monitor and
manage pain among severely injured military personnel, veterans, and civilians.
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